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ABSTRACT: 
Adult onset neurodegenerative diseases present a major health problem, especially with 
an aging population. The contribution of glia cells and their interactions with neurons in 
the onset and progression of neurodegenerative processes is not well understood. Glia 
cells are crucial regulators of the nervous system as their functions include providing 
trophic support to the neurons, assistance in axonal guidance and fasciculation, neuronal 
insulation, neurotransmitter clearance and recycling from synaptic cleft, as well as 
maintaining ionic homeostasis. Glia malfunction has been associated with axonal 
degeneration in many neurodegenerative diseases. My research goal is to investigate the 
role of glia in neurodegeneration using Drosophila melanogaster as a genetic model 
system. The focus of the present research is to identify the specific subsets of glia that are 
critical for neurodegeneration and neuroprotection. In Drosophila melanogaster glia cells 
account for 10% brain cells compared with 90% in mammalian, making Drosophila an 
ideal model to understanding the role of glia on nervous system survival, function and 
behavior. Anaphase-Promoting Complex/cyclosome APC/C is a E3 ubiquitin ligase 
complex well characterized for its role in cell cycle progression. Rap/Fzr is a Drosophila 
homologue of the mammalian Cdh1, which serves as a regulatory subunit of the APC/C. 
By performing various assays such as temperature sensitive paralysis, monitoring 
lifespan and brain morphology, we present data demonstrating the effects of Expression 
of Rap/Fzr in different subsets of glia. Amongst various subsets of glia, astrocyte-like 
glia exhibits more severe neurodegenerative phenotypes. Thus, we propose that astrocyte-
like glia facilitate the neuroprotective properties of glia and overall neuron-glia 
interactions. 
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INTRODUCTION: 
In recent years it has become clear that glia are essential for proper nervous system 
development and function.  Glial cells provide support and protection to the intricate 
systems of neuronal connections responsible for processing and relaying information.  
Although differences exists in aspects of glial development and fate determination among 
vertebrate and invertebrate organisms, one large similarity is that glia functions are 
comparable in insects and mammals (Freeman and Doherty 2006). Glia of the central 
nervous system (CNS) participate in a number of functions including axon guidance and 
fasciculation (Hidalgo and Booth 2000), neuron survival (Booth, Kinrade et al. 2000) and 
engulfing degenerating axons during axon pruning and post-injury (Awasaki and Ito 
2004; Watts, Schuldiner et al. 2004). Thus, proper formation of glia is essential for the 
correct patterning and development of the nervous system. To understand the functional 
role of glia in neurodegeneration and neuroprotection, we are using Drosophila 
melanogaster as a model system. Drosophila melanogaster is readily amenable to 
genetic, molecular, behavioral, and cell biological experiments. The ready amenability of 
the Drosophila genome to molecular and genetic manipulation makes it an ideal system 
to work with.  Drosophila melanogaster is especially useful for studying the role of glia 
because of their relatively lower abundance in CNS and PNS accounting for 
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Background:  
Organization of the Drosophila CNS 
Drosophila Brain anatomy:  
 
Figure 1: lamina (La), medulla (Me) and lobula (Lo), The antennal lobes (AL) and mushroom bodies 
(MB) 
 (Edwards and Meinertzhagen 2010) 
 
The Drosophila central nervous system consists of ganglia, which supply nerves to it 
respective segments in the body. There are three major ganglia in the head which are 
protocerebrum, deutocerebrum, and tritocerebrum. (“Form and Function (Insects)." 
Animal Aqua. 16 Dec. 2006. Web. 14 May 2011. <http://www.animalaqua.com/form-
and-function-insects/>).  The protocerebrum region is composed of lamina, medulla and 
lobula. Deutocerebrum processes sensory information, consists of the antennal lobes 
(AL) and mushroom bodies (MB) (Edwards and Meinertzhagen 2010). 
 Types of glia: 
 
Figure 2: cartoon of surface (light grey), cortex (medium grey) and neuropile (dark grey) 
(Edwards and Meinertzhagen 2010) 
 
Drosophila glia have been classified into different subtypes based on their location and 
morphology. These include the cortex glia , perineurial glia and subperineurial glia of the 
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surface glia, ensheathing glia and astrocyte-like glia of the neuropile subtype (Freeman 
and Doherty 2006; Awasaki, Lai et al. 2008; Edwards and Meinertzhagen 2010). 
Surface glia look flat and are composed of perineural and subperineural glia (Awasaki, 
Lai et al. 2008). These two types of glia differ in their shape and position within the 
Brain. Perineurial glia have elongated nuclei and they reside at the ganglionic surface 
(reviewed in (Edwards and Meinertzhagen 2010). Perineural glia develop 
postembryonically and do not require glia cell missing (gcm) gene for their 
developmental fate (Awasaki and Ito 2004). Perineural glia have been shown to function 
in the formation of Blood Brain Barrier (BBB) of the adult flies. The perineurial glia 
derive from the mesoderm (Edwards, Swales et al. 1993) and do not express the glia cell 
marker repo early in their early development such as larval instar1 and instar2 stage 
(Hartenstein, Nassif et al. 1998). However, they do express the glia cell marker repo 
during early pupal stages (Awasaki, Lai et al. 2008; Stork, Engelen et al. 2008). 
Subperineurial glia are a major component of larval BBB as they help in the formation 
of the septate junctions, which are a major characteristic of BBB.  They form an inner 
layer of large, sheet-like glia and along with perineural glia at the ganglionic surface 
(Bainton, Tsai et al. 2005; Schwabe, Bainton et al. 2005; Stork, Engelen et al. 2008). 
Cortex glia form a mesh in the cortex region of the brain. Cortex glia enwrap many 
neuronal cell bodies (Freeman and Doherty 2006; Awasaki, Lai et al. 2008). In the cortex 
region of the CNS, cortex glia are embedded among the neurons and keep a close contact 
with the somata of the neurons. 
(Edwards and Meinertzhagen 2010). 
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Figure 3: en- ensheathing glia, ag- astrocyte glia (Edwards and Meinertzhagen 2010) 
 
Neuropile glia are associated with axonal guidance and fasciculation as they are located 
in the synaptic neuropil (Awasaki, Tatsumi et al. 2006). Neuropile glia extend their 
sheath-like membranes around axon bundles. Based on their morphology, they are 
thought to promote neuronal survival by providing trophic support (Awasaki, Tatsumi et 
al. 2006). Neuropile glia can be categorized as ensheathing or astrocyte - like. 
Ensheathing glia are present in the lamina region and reside along the outer surface of 
the neuropile and are presumed to perform phagocytic activities after neuronal death 
(Awasaki, Tatsumi et al. 2006; Awasaki, Lai et al. 2008; Edwards and Meinertzhagen 
2010). Astrocyte glia are found in the synaptic regions and control neuronal connection. 
These glia have extended projections and are connected to more than one neuron 
(reviewed in Edwards and Meinertzhagen 2010).  In Drosophila astrocyte glia were 
recently identified and isolated (Awasaki, Lai et al. 2008). In Drosophila, astrocyte-like 
glia express amino acid transporters EAATs, which are required for the clearance of 
excess neurotransmitters at the synaptic cleft and are responsible for modulating synapse 
formation and signaling (Seal and Amara 1999; Doherty, Logan et al. 2009).  
Differences and similarities between vertebrate and invertebrate glia: 
The most obvious difference between mammalian and insect glia is their numbers in the 
CNS. In mammalian brain, glia accounts for ~90% of total cells, whereas in 
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invertebrates, glia account for ~10% of the cells in the CNS (Pfrieger and Barres 1995). 
Furthermore, Glia Cell Missing (gcm), which is essential for glia specification in 
Drosophila (Jones, Fetter et al. 1995), is not so in mammals (Kim, Jones et al. 1998). 
There are many similarities between mammalian and invertebrate glia with regard to 
structure and function. For example, neuropile glia could be considered similar to 
mammalian oligodendrocyte glia because they enwrap and guide axons during 
development like the oligodendrocytes (Chotard and Salecker 2004; Edwards and 
Meinertzhagen 2009; Edwards and Meinertzhagen 2010). Cortex, surface and neuropile 
glia all are presumed to function like mammalian microglia as they collectively perform 
phagocytic activity and help clear degenerating neurons (Freeman and Doherty 2006). 
Cortex glia, which are embedded in the CNS cell cortex, provide trophic support to the 
neuron (Freeman and Doherty 2006).    
Table 1: vertebrate and invertebrate glia:  similarities 
Vertebrate glia 
subtype 





Trophic support of 
neurons, synapse 
modulation 





Cortex glia (and a 
perineural glia of the 
surface glia subtype) 
Oligodendrocytes 
Neuronal ensheathment, 













Cortex, surface and 
neuropil glia 











Glia control glutamate and glucose recycling: 
In Drosophila, glutamate is an important neurotransmitter because of its involvement in 
regulating synaptic connections. Extracellular glutamate levels have been shown to 
regulate number of postsynaptic glutamate receptors (Grunwald, Mellem et al. 2004). 
Shish et al. (2006), showed that in mammals, ionotropic glutamate receptors (iGluRs) 
mediate neurotransmission between adjacent neurons (Shih, Erb et al. 2006). The 
cystine/glutamate exchange system is an important regulator of synaptic iGluRs at the 
synaptic cleft. One of the cystine/glutamate transporters is xCTs. Altering the activity of 
the amino-acid transporters changes glutamatergic transmission, which in turn also 
regulates homosexual behavior in Drosophila (Grosjean, Grillet et al. 2008). One such 
gene for the Drosophila cystine/glutamate transporters was identified and named 
“genderblind”(Augustin, Grosjean et al. 2007). Genderblind is expressed in perineural 
glia. Genderblind xCT transporter secretes glutamate into the extracellular space. 
Augustin et al. (2007), showed that glutamate concentration in hemolymph is reduced in 
genderblind mutants (Augustin, Grosjean et al. 2007). The genderblind mutants also 
show a vast increase in glutamate receptors at neuromuscular junction which suggest that 
glia xCT transporters secrete glutamate which in-turn desensitizes receptors and 
desensitization inhibits glutamate receptor clustering at synapses (Augustin, Grosjean et 
al. 2007; Jackson and Haydon 2008).  
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In mammalian systems, astrocyte glia cells have also been shown to be the primary site of 
glucose uptake, where glucose is processed glycolytically (Barres 1991). Upon uptake, 
astrocytes release lactate (mammalian) or alanine (insects) as the metabolic substrate, 
which, is then to be used by neurons (Edwards and Meinertzhagen 2010).  Astrocyte glia 
are also involved in the clearance of potassium. Astrocytes are highly permeable to 
potassium as they express potassium channels(Jalonen and Holopainen 1989). During 
axonal conduction, extracellular potassium levels are elevated. At this time astrocytes 
uptake potassium via the potassium channels embedded in their membranes and rapidly 
clear the excess accumulation of potassium in the extracellular space (Barres 1991). 
Astrocyte glia assistance in potassium clearance which along with glucose regulation 
increases extracellular space as well as promotes synaptic activation (Barres 1991). 
Glia and neuronal survival:  
Studies by Xiong and Montell, (1995) and Booth et al., (2000) have indicated that glia are 
essential for neuronal survival (Xiong and Montell 1995; Booth, Kinrade et al. 2000).  In 
larval CNS of Drosophila, loss of function mutation of gcm, which suppresses glia fate or 
glia loss by targeted glia dysfunction, leads to neuronal apoptosis (Booth, Kinrade et al. 
2000). Nonfunctional glia that surround photoreceptor axons in the lamina and in the 
cortex regions cause an increased cell death (Xiong, Okano et al. 1994; Xiong and 
Montell 1995). 
Glia and neurodegeneration: 
Microglia participate in the degradation of abnormal protein deposits and invading 
microbes along with removal of degenerating host cells (Wyss-Coray and Mucke 2002). 
Studies have shown that microglia and astrocytes can ingest and degrade amyloid plaques 
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(a common component of Alzheimer‟s autopsy brain) (Wyss-Coray and Mucke 2002). 
Glia are also responsible for providing neurotrophic factors. Drosophila neurotrophic 
factor DmMANF (a homologue of mammalian MANF and CDNF), which is expressed in 
glia cells, is essential for proper functioning of dopamine positive neurons (Palgi, 
Lindstrom et al. 2009). Studies have shown that abolishment of neurotrophic factors that 
are expressed in glia, lead to degeneration of axonal bundles in the embryonic central 
nervous system and nonapoptotic cell death (Palgi, Lindstrom et al. 2009) 
Glia and Blood Brain Barrier: 
In vertebrates, tight junctions between endothelial cells layer in the CNS form the 
primary barrier to extracellular flow and prevent the diffusion of lipids and proteins 
across the apical and basolateral plasma membrane (reviewed in (Coisne and Engelhardt 
2011). In invertebrates, such as Drosophila, there is no closed circulatory system and the 
CNS must be isolated from the open circulation of hemolymph which is composed of 
high potassium (van Meer and Simons 1986). In Drosophila, the intercellular Septate 
junctions formed by the surface glia create the blood brain barrier. Surface glia come 
together and form a single- layer epithelium late in development (Schwabe, Bainton et al. 
2005). A G-protein coupled receptor moody, along with the G protein α subunits (Gi and 
Go), and loco (the regulator of the α subunits) are expressed in surface glia and this 
complex is essential for proper barrier formation (Schwabe, Bainton et al. 2005). Loss of 
moody results in leaky blood–brain barrier because moody mutants fail to properly 
regulate the assembly of septate junctions for the barrier indicating that GPCR signaling 
plays a crucial role in the insulation of the nerve cord (Carlson, Juang et al. 2000; 
Bainton, Tsai et al. 2005; Schwabe, Bainton et al. 2005; Edwards and Meinertzhagen 
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2010). Glia help ensure that central nervous system is in a proper ionic and biochemical 
environment. In Drosophila, glia ensheath axons thus, shielding them against the high 
potassium concentration of the hemolymph. Slight disruption of the blood brain barrier 
causes many behavioral defects (Schwabe, Bainton et al. 2005). If ensheathment is 
disrupted and neurons are exposed to the hemolymph, their resting potential is obstructed 
and action potential can no longer propagate (Auld, Fetter et al. 1995). Such hindrance in 
action potential propagation results in paralysis and other behavior defects in flies 
(Schwabe, Bainton et al. 2005; Banerjee, Sousa et al. 2006; Banerjee, Bainton et al. 2008; 
Stork, Engelen et al. 2008; Banerjee, Blauth et al. 2010).  
Glia and neurons: 
Glia are required for the proper development and neuronal survival. Neurons and glia 
work in coordination and assist each other when integrity of one is threatened. 
Importance of glia in maintaining neuronal integrity comes from studies on drop dead 
Drosophila mutant(Buchanan and Benzer 1993). These studies showed that in drop dead 
mutant flies, glia cells are arrested in the early stages of development and fail to form a 
complete glia sheath hence, undergo age-dependent neurodegeneration and early death 
(Buchanan and Benzer 1993; Rogina, Benzer et al. 1997). Buchanan and Benzer 
examined drop-dead mutant brain prior to onset of symptoms and discovered that glia 
cells are immature and there is incomplete glia enwrapping of neurons. Dysfunctional 
glia in drop-dead mutants disrupt adult nervous system function contributing to 
progressive brain degeneration and death (Buchanan and Benzer 1993).  
Another important contributor to understanding the role of glia in neurodegeneration 
comes from works byKretzschmar, Hasan et al. (1997), as they studied behavioral 
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phenotypes of a Drosophila mutant called swiss cheese (sws). sws is expressed in the 
endoplasmic reticulum of neurons and some glia (Muhlig-Versen, da Cruz et al. 2005). 
The sws gene is a homologue of the Neuropathy Target Esterase (NTE) protein that codes 
for a brain-specific phospholipase (Muhlig-Versen, da Cruz et al. 2005). Both sws and 
NTE regulate the deacylation of phosphatidylcholine (PtdCho), a major lipid of cell 
membranes which is elevated in sws mutants (Zaccheo, Dinsdale et al. 2004; Muhlig-
Versen, da Cruz et al. 2005). In sws mutants, excess of glia wrapping of neurons is seen 
which, causes neuronal death (Kretzschmar, Hasan et al. 1997). Such defects in glia 
wrapping are thus presumed to be the cause of massive degeneration seen in sws mutants 
(Buchanan and Benzer 1993; Kretzschmar, Hasan et al. 1997).  
The reversed polarity (repo), another Drosophila mutant, repo encodes a glia- specific 
protein. repo is required for terminal differentiation of glia in the Drosophila visual 
system as it is expressed in the laminar and medullar part of the optic lobes (Xiong, 
Okano et al. 1994). A study by Xiong et al shows that neuronal survival in the lamina 
depends on repo expression in the laminar glia suggesting its role to supply factors 
required for neuronal survival (Xiong and Montell 1995).  
In Drosophila, glia have also been shown to present phagocytic activity after acute 
axotomy as they expresses key component of phagocytic machinery (the engulfment 
receptor, Draper (Doherty, Logan et al. 2009). Draper (Drpr), the Drosophila ortholog of 
the C. elegans cell corpse engulfment receptor CED-1 that is similar to human SREC 
(Scavenger Receptor from Endothelial Cells) encodes an engulfment receptor essential 
for clearance of degenerating axons from the injured brain (Doherty, Logan et al. 2009)). 
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Draper receptor transcription is initiated in glia when their host axons undergo 
degeneration (Doherty, Logan et al. 2009).  
Glia Axon guidance: 
Glia role in axon guidance and fasciculation was shown by Slit/Roundabout studies.  
Specialized midline glia (MG) attract or repulse axons by secreting ligands(Simpson, 
Bland et al. 2000; Beckervordersandforth, Rickert et al. 2008). Neurexin IV (Nrx IV) is a 
Drosophila transmembrane septate junction-specific protein (Banerjee, Blauth et al. 
2010). Nrx IV is also expressed in the neurons of the developing ventral nerve cord. 
Studies have reported that Nrx IV functions in midline repulsive axon guidance 
(Banerjee, Blauth et al. 2010). Nrx IV is required for repulsion of axons guidance as it 
interacts with Robo plays an essential role in “proper Robo localization in CNS” 
(Banerjee, Blauth et al. 2010) 
Glia and Circadian Rhythm: 
In Drosophila, circadian rhythms are controlled by clock genes such as timeless, period, 
cycle, and dclock (Helfrich-Forster 1995; Boothroyd and Young 2008; Helfrich-Forster 
2009). The period genes are expressed in glia and neurons (Ewer, Frisch et al. 1992). 
Some clock neurons also express the neuropeptide Pigment Dispersing Factor (PDF), 
which is released to regulate cells downstream in the circadian pathway (Lear, Merrill et 
al. 2005; Mertens, Vandingenen et al. 2005; Ng, Tangredi et al. 2011). In a study by Ng. 
et al., (2011) conditional glia-specific manipulations that affects membrane trafficking, 
ionic gradient and calcium levels leads to changes circadian rhythm in adult flies. 
Astrocyte- like glia specific changes lead to severe arrhythmicity s (Ng, Tangredi et al. 
2011). This study provides a possible role of astrocyte-like glia in Drosophila 
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melanogaster as an important contributor to the conservation of cellular and molecular 
mechanisms that regulate behavior in mammals and insects (Ng, Tangredi et al. 2011).  
Glia Differentiation: 
 
Figure 4: Schematic of glia differentiation. 
During embryogenesis, glide (glial cell deficient)/glia cell missing (gcm) plays an 
essential role in glia development and identity. It was shown by (Vincent, Vonesch et al. 
1996), that glide glial cell deficient)/gcm is expressed in all Drosophila embryonic glia 
except for midline glia (Vincent, Vonesch et al. 1996). During development, Ganglion 
Mother Cells (GMC) which do not express glide/gcm develop into neurons. (Hosoya, 
Takizawa et al. 1995; Jones, Fetter et al. 1995; Vincent, Vonesch et al. 1996; Freeman 
and Doe 2001). Studies have shown that in Drosophila gcm loss-of-function mutant 
embryos show a transformation of CNS glia into neurons (Hosoya, Takizawa et al. 1995; 
Jones, Fetter et al. 1995; Vincent, Vonesch et al. 1996). Conversely, overexpression of 
gcm causes an increased expression of glia-specific genes (Jones, Fetter et al. 1995). gcm 
initiates the glia determination pathway and activates downstream targets such as 
reversed polarity (repo), pointed (pnt), tramtrack (ttk) and locomotion defects (loco) 
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which regulate differentiation and maintenance of the glia cell fate as well as play a role 
in glia development (Klambt, Jacobs et al. 1991; Klambt 1993; Klaes, Menne et al. 1994; 
Xiong, Okano et al. 1994; Halter, Urban et al. 1995; Giesen, Hummel et al. 1997; Miller, 
Bernardoni et al. 1998; Granderath, Stollewerk et al. 1999; Granderath, Bunse et al. 2000; 
Badenhorst 2001). Recent studies have shown that gcm down-regulates the activity of a 
transcriptional regulator Dachshund, which is required to make lamina precursor cells 
and lamina neurons (Chotard, Leung et al. 2005). 
repo is expressed in all glia (except for midline glia) and is used as a general marker for 
these cells. Together with Pnt, Repo promotes glia fate, while ttk suppresses the neuronal 
fate (Yuasa, Okabe et al. 2003).  Although, the exact cellular mechanisms are not clear of 
how gcm controls glia fate, it is understood that gcm is necessary and sufficient for 
driving glia development during embryogenesis. Using transgenic flies with different 
gcm mutants, Freeman et al. (2006), identified different subsets of glia in Drosophila 
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Ubiquitin Proteosome system (UPS) 
 
Figure 5: Ubiquitin Proteosome pathway 
http://faculty.ucr.edu/~karinel/research.html 
 
Ubiquitin Proteosome is a major degradation pathway. The degradation of proteins is 
critical for intracellular signaling and cellular maintenance. Its primary function is to 
eliminate damaged proteins. Ubiquitin is a small, 76 amino acid protein, which is 
attached to the target proteins. The ubiquitin has an attachment sites on the C-terminus 
where ubiquitin is added to the lysine residue. Ubiquitination is regulated by three 
enzymes which, are E1 (activating enzyme), E2 (conjugating enzyme), and E3 (ligating 
enzyme) (King, Peters et al. 1995). After ubiquitin binds E1, it is activated and 
transferred to E2 forming a thioester bond and then ubiquitin is transferred from E2 via 
E3 to the target site (McNaught, Olanow et al. 2001). The E3 ubiquitin ligase contains 
RING finger domain in which cysteine and histidine residues are ligands to two zinc ions. 
RING E3 allows for the direct transfer of ubiquitin from E2-Ubiquitin to substrate. A 
protein can be mono or poly ubiquitinated. Monoubiquitination leads to conformational 
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changes whereas polyubiquitionation of 4 or more residues targets proteins for 
degradation by 26S proteosome (Deshaies and Joazeiro 2009).  
The 26S proteasome is a large complex consisting of at least 66 proteins. The 26S 
proteosome is responsible for degradation of cyoplasmic, nuclear and membrane proteins 
where ubiquitin is recycled but not degraded. Ubiquitin-proteosome is also involved in 
axon pruning and wallerian degeneration (Korhonen and Lindholm 2004; Murata, 
Yashiroda et al. 2009)). 
 
Anaphase Promoting Complex/Cyclosome 
 
Figure 6: Anaphase promoting complex in mammalian system 
(Peters 2006) 
 
Anaphase Promoting Complex (APC/C) is a multi-subunit protein with ubiquitin ligase 
activity. It is expressed in brain tissue and is needed for cell-cycle transitions (metaphase 
to anaphase) (King, Peters et al. 1995). Cdh1 is a regulatory subunit of the mammalian 
APC/C and it is highly expressed in the post mitotic neurons (Gieffers, Peters et al. 
1999). In vertebrate systems, Cdh1 binds substrates through its interaction with the D box 
(Destruction box), KEN box (KENxxxN), A-box, and CRY box (Kaplow, Mannava et al. 
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Rap (retina aberrant in pattern) encodes the Fizzy-related protein (Fzr) (Pimentel and 
Venkatesh 2005). Rap/Fzr (Retina aberrant in Pattern/Fizzy related) is a regulatory( 9
th
) 
subunit of the APC/C and is the Drosophila homolog of the mammalian Cdh1. Rap/Fzr 
has been shown to be involved in the regulation of  mitosis as shown in the developing 
wing imaginal disc and eye-antennal disc (Karpilow, Pimentel et al. 1996; Sigrist and 
Lehner 1997; Pimentel and Venkatesh 2005). APC/C along with Rap/Fzr is activated 
during the metaphase of cell cycle. Current model suggests that Rap/Fzr facilitates in 
determining substrate specificity of the APC/C. During metaphase, Rap/Fzr targets 
mitotic cyclins, cyclin B for degradation and promotes the cell to undergo anaphase and 
thus, facilitates cell-cycle exit (Kaplow, Mannava et al. 2007). Studies by Pimentel and 
Venkatesh (2005), show that in partial loss-of-function mutants of Rap/Fzr, there is an 
accumulation of the mitotic cyclins resulting in abnormal mitosis  in the developing eye, 
which lead to the rough eye phenotype (Karpilow, Pimentel et al. 1996; Pimentel and 
Venkatesh 2005; Kaplow, Mannava et al. 2007). In the neuromuscular junction, the 
APC/C has been shown to regulate synaptic size and function (van Roessel, Elliott et al. 
2004). Mammalian Cdh1 has been shown to be involved in axonal guidance and 
fasciculation, as knockdown of Cdh1 cause increased axon growth and defasciculation 
(Konishi, Stegmuller et al. 2004). Kaplow et al. (2007) identified Loco as a genetic 
modifier of the rough eye phenotype (eye phenotype of the rap/fzr loss-of-function 
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mutants) (Kaplow, Mannava et al. 2007). Further work has shown that Rap/Fzr targets 
Loco for ubiquitination and proteasomal degradation and thus regulates gliogenesis 
(Karpilow, Kolodkin et al. 1989; Kaplow, Mannava et al. 2007; Kaplow, Korayem et al. 
2008). Analysis of loss-of-function and gain-of function mutants further supports a role 
for Rap/Fzr in gliogenesis. Rap/Fzr loss-of-function mutants show greatly increased glia 
cell numbers compared to wild type and reduced neuronal number (Kaplow, Korayem et 
al. 2008).  
 
Loco  
The regulators of G-protein signaling (RGS) are an important family of proteins critical 
in the regulation of signaling mediated by G-coupled receptors [GPCR] (Yu, Wang et al. 
2005). GPCRs are found at the cell surface and are linked to the G protein to initiate a 
signaling cascade (Ponting 1999).  In Drosophila, several genes, such as axin, gprk 2 and 
loco are known to encode RGS proteins in Drosophila (McGurk, Pathirana et al. 2008). 
Locomotion defects (loco) encodes a member of an RGS protein family and is involved in 
the G-protein signaling. Loco is required for the ensheathment of the neuronal bodies and 
axons and proper development of the blood brain barrier (Granderath, Stollewerk et al. 
1999; Ponting 1999). The primary functional roles of Loco are in the formation, 
extension and migration of glia cells and the asymmetric division of neuroblasts (Yu, 
Wang et al. 2005). It was shown that the loco gene function is required for glia 
differentiation and triggers glia migration or differentiation in the brain but the exact 
mechanisms are not known (Yu, Wang et al. 2005); Ponting 1999).  
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Recent evidence demonstrates that Rap/Fzr physically interacts with Loco and 
may target Loco for ubiquitination and proteasomal degradation, indicating a novel role 
for Rap/Fzr in regulating glial development (Karpilow, Kolodkin et al. 1989; Kaplow, 
Mannava et al. 2007; Kaplow, Korayem et al. 2008). The molecular pathways and 
morphological stages of glial development have been intensively studied during 
embryogenesis (reviewed in Jones, Fetter et al. 1995) and factors influencing 
postembryonic glial development have recently begun to come to light (Pereanu, Shy et 
al. 2005). Third instar larvae of rap/fzr loss-of-function mutants (w,rap
3
) show greatly 
increased glial cell numbers compared to wild type (Canton-S), while targeted 
overexpression of rap/fzr resulted in loss of surface glia (Kaplow, Korayem et al. 2008). 
In addition, adult phenotypes resulting from pan-glia driven overexpression of rap/fzr 
leads to life span reduction, paralysis and vacuolization in the brain tissue. The present 
research was undertaken to test the gain-of-function phenotypes following glia subset 
specific overexpression of rap/fzr. 
MATERIALS and METHODS: 
UAS-GAL4 system: 
Gal4-UAS system  as described in Brand, et al., 1993 (Brand and Perrimon 1993) was 
used to target expression of Rap/Fzr. UAS/GAL4 system allows direct measurements of 
the effects of expression of a gene of interest. The gene for GAL4, a transcriptional 
activator from yeast is injected under the regulation of the  Drosophila enhancer/trap so 
that it is expressed in tissue specific manner (St Johnston 2002). UAS (upstream activator 
sequence), upon binding to the GAL4 driver, activates the expression of the gene of 
interest in the respective tissue which is targeted by the GAL4 driver. The gain-of-
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function experiments are a useful way to study the effects of the overexpression of a 
given protein. Both GAL4 and UAS-rap/fzr are carried in different strains, allowing the 
parental viability. It also allows for the GAL4 to be expressed in a spatial pattern; thus, 
depending on the tissue promoter used the gene under UAS can be overexpressed in a 
variety of tissues if crossed to the GAL4 line (McGuire, Roman et al. 2004).  
The Rap/Fzr gene was cloned downstream of a UAS sequence and the gene expressed in 
the presence of GAL4 protein that binds to the UAS and activates transcription. 
Glia-specific GAL4 drivers of pan glia and different subsets of glia were used to target 
Rap/fzr expression to glia cells.  
Fly stocks and crosses 
 
The stocks were maintained at 25°C on standard corn meal-agar medium. 
Stocks: 
 
Pan glia gal4 driver used:  
+/+; Repo-GAL4/TM6,Tb;+/+, 
Glia subset Gal4 drivers: 
NP6293 (perineural glia ) - y[*] w[*]; P{w[+mW.hs]=GawB}Bsg[NP6293] / CyO, P{w[-
]=UAS-lacZ.UW14}UW14  this subsets.  
NP 2276 (Sub-perineural glia )- w[*]; P{w[+mW.hs]=GawB}spin[NP2276] / CyO 
NP2222 (cortex glia) - w[*]; P{w[+mW.hs]=GawB}Akap200[NP2222] / CyO  
NP577 (cortex glia)- w[*] P{w[+mW.hs]=GawB}NP0577 / FM7c 
NP 3233 (astrocyte-like glia) - w[*]; P{w[+mW.hs]=GawB}NP3233 
NP 1243 (astrocyte-like glia)- y[*] w[*]; P{w[+mW.hs]=GawB}wun[NP1243] / Cyo, 
P{w[-]=UAS-lacZ.UW14}UW14  
NP6520 (ensheathing glia)- y[*] w[*]; P{w[+mW.hs]=GawB}NP6520 / TM6, P{w[-
]=UAS-lacZ.UW23-1}UW23-1  
 
Subset of glia Gal4 drivers were obtained from T.  Lee.  We have more than one Gal4 
driver for one subset of glia such as NP 3233 and NP 1243 are gal4 drivers for astrocyte-
like glia. This is so, because the GAL4 enhancer trap is placed upstream in a tissue 
specific manner. The tissue is targeted by the presence of certain known gene or a 
particular sequence within the tissue of interest. Thus, NP1243 driver is placed upstream 
of wunen gene, which is located in the brain neuropils. NP3233 is placed upstream of an 
unknown gene but a known sequence, which is also expressed, in neuropile regions of the 
brain.  
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Strains exhibiting targeted expression of Rap/Fzr in specific glia subtypes: 
 
w[*]/+;P{w[+mW.hs]=GawB}NP3233/+;733 UAS-rap/fzr /+ 
w[*]/+;P{w[+mW.hs]=GawB}wun[NP1243] / +; 733 UAS-rap/fzr /+  
w[*]/+; P{w[+mW.hs]=GawB}NP6520 / +;733 UAS-rap/fzr /+ 
w[*] P{w[+mW.hs]=GawB}NP0577 / +; +/+;733 UAS-rap/fzr /+   
w[*]/+;P{w[+mW.hs]=GawB}Akap200[NP2222]/+;733 UAS-rap/fzr /+  
y[*] w[*]/+; P{w[+mW.hs]=GawB}Bsg[NP6293]/+;733 UAS-rap/fzr /+    
w[*]/+;P{w[+mW.hs]=GawB}spin[NP2276] / +; 733 UAS-rap/fzr /+ 
 
Control strains 










+/+;Repo Gal4/TM6,tb;+/ UAS-APC2 
+/+;Repo Gal4/TM6,tb;+/ 733 UAS-Rap/Fzr 
Elav Gal4/+;+/733 UAS-Rap/Fzr 
 
Genetic Crosses: 
Isofemale UAS-Rap/fzr flies were crossed to males of pan-glia Gal4 driver (repo-Gal4) or 
glia subset drivers. Parents were removed after one week of mating and non-balancer 
progeny were collected the following week. The selected flies were used to perform 





Paralysis is defined as the condition in which the fly lies on its back with little effective 
movement of the legs and wings. 10-15 flies of mutant and control genotypes were 
transferred into clear glass vials. The vials were preheated in water baths of 28ºC, 32ºC or 
37ºC for approximately half an hour prior to the transfer of flies to ensure a consistent 
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temperature throughout the vials.  Paralyzed flies were counted at 4-minute periods for 12 
minutes.  After 12 minutes the vials were removed from the water bath and placed on the 
bench at room temperature to allow the paralyzed flies to recover. Flies were allowed to 
rest after each treatment.  After the 37ºC treatment the flies were returned to food vials.  
Flies were transferred to fresh food vials several times a week. 
Lifespan measurement assay:  
Flies of each genotype were collected using gaseous carbon dioxide and kept on standard 
cornmeal media at 25°C. Flies were maintained in non-crowded conditions of 1 to 20 
flies per vial. Flies were transferred to fresh media every four days and scored for the 
presence of dead adults. Survival data was transferred to the GraphPad Prism 5 program 
and were compared using ANOVA. Significance was considered to be 95%, with P < 
0.05. 
Toulidine blue staining for brain morphology: 
Four week old adult Drosophila brains were first fixed in a primary fixative containing 
0.2M sodium cacodylate buffer, pH 7.2, 10% glutaraldehyde and 16% paraformaldehyde 
for 4 hours.  Brain samples were then rinsed in buffer and post-fixed in osmium tetroxide.  
After post-fixation, the brain samples were then dehydrated in graded series of different 
concentrations of ethanol followed by a 5 minute rinse in propylene oxide and then 
incubated in 100% resin containing Embed 812, Dodecenyl Succinic Anhydride (DDSA), 
Nadic Methyl Anhydride (NMA) and DMP-30 (a tertiary amine epoxy accelerator) for 2 
days in a 60˚C oven temperature. Resin blocks are recovered and sectioned with thick of 
1 μm. The sectioned were stained with 10% Toulidine blue for 2-3 minutes. The stain 
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was washed with distilled water and the sections were then analyzed under light 
microscope.   
RESULTS: 
Glia targeted expression of Rap/Fzr leads to Temperature Sensitive Paralysis 
The temperature-sensitive paralysis phenotype has been successfully used to discover genes 
with crucial roles in neural function (Palladino, Hadley et al. 2002). The identification of genes 
that, when mutated, cause conditional paralysis phenotypes, provides valuable insights into the 
molecular pathways involved in nervous system function. For example, the well-known 
temperature-sensitive locus, shibire, encodes dynamin, a GTPase required for synaptic vesicle 
endocytosis (Grigliatti, Hall et al. 1973; Kawasaki, Hazen et al. 2000). A mutation in a sodium 
channel subunit, para
ts
, results in impaired action potential propagation and temperature-
sensitive paralysis (Suzuki, Grigliatti et al. 1971). In addition to these classically isolated 
alleles, a large number of temperature-sensitive paralytic mutants have subsequently been 
isolated (Vijayakrishnan and Broadie 2006). Preliminary observations of rap/fzr gain-of-
function mutants revealed motility defects indicative of possible paralysis at elevated 
temperatures. Previous studies in this laboratory by Rosa Mino have showed that expression of 
Rap/Fzr in glia using Repo-GAL4, a panglial Gal4 driver results in severe paralysis when 
shifted 38
 o
C (Fig.7). The extent of paralysis increased with age, degree of temperature 
increase and duration spent at the increased temperature. The percent paralysis exhibited by 
these flies increases dramatically with age as 1 week old flies exhibit 15 % paralysis compared 
to the 4 weeks old flies which show a 100 % paralysis after being in the elevated temperature 
for approximately 2 minutes (Fig.7) 
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In order to determine which specific subtype of glia mediates the exhibited paralytic behavior 
in pan-glia driven overexpression of rap/fzr, we tested glia subtype specific GAL4 drivers. We 
have obtained GAL4 lines, which express GAL4 drivers in different subsets of glia. In 
Drosophila, there are three major types of glia, which are distinguished, based on their location 
within the brain. The three major types of glial cells are surface glia, cortex glia and neuropil 
glia. These types of glia are further subdivided into different subsets of glia which, differ in 
their morphology and positioning within the CNS. The five different subsets of glia 
distinguished so far are cortex glia, astrocyte-like glia, ensheathing glia, perineural glia and 
subperineural glia. We obtained GAL4 drivers for these different subsets of glia. The GAL4 
lines are activated upon the binding to the UAS (Upstream Activation Sequence) and activate 
rap/fzr transcription. This method allows for targeting of the expression of rap/fzr in subsets of 
glia and allows us to understand its possible role of different subtypes of glia in Drosophila 
brain. To assess the role of glia subtypes, UAS-rap/fzr was crossed to the   following subtype 
specific NP GAL4 lines as shown in the table below. 
Table 2 
Genetic crosses  
 
GAL4 driver                                    x      UAS-rap/fzr 
Progeny genotype 





+;733 UAS-rap/fzr /+ 
Astrocyte-like glia-  
w[*];P{w[+mW.hs]=GawB}wun[N




1243] / +; 733 UAS-rap/fzr /+  
 
Ensheathing glia-  
w[*];P{w[+mW.hs]=GawB}NP652
0 / TM6, P{w[-]=UAS-lacZ.UW23-
1}UW23-1 
 
+/+;+/+;733 UAS-rap/fzr w[*]/+; P{w[+mW.hs]=GawB}NP6520 
/ +;733 UAS-rap/fzr /+ 
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Cortex glia-  
w[*];P{w[+mW.hs]=GawB}NP057
7 / FM7c; +/+;+/+ 
 
+/+;+/+;733 UAS-rap/fzr w[*] P{w[+mW.hs]=GawB}NP0577 / 
+; +/+;733 UAS-rap/fzr /+   
Cortex glia-  
w[*];P{w[+mW.hs]=GawB}Akap2
00[NP2222] / CyO; +/+ 
 
+/+;+/+;733 UAS-rap/fzr w[*]/+;P{w[+mW.hs]=GawB}Akap200
[NP2222]/+;733 UAS-rap/fzr /+  
 
Perineural glia-  
y[*] w[*]; 
P{w[+mW.hs]=GawB}Bsg[NP629
3] / CyO, P{w[-]=UAS-
lacZ.UW14}UW14;+/+   
 
+/+;+/+;733 UAS-rap/fzr y[*] w[*]/+; 
P{w[+mW.hs]=GawB}Bsg[NP6293]/+;




P2276] / CyO;+/+ 
 
+/+;+/+;733 UAS-rap/fzr w[*]/+;P{w[+mW.hs]=GawB}spin[NP
2276] / +; 733 UAS-rap/fzr /+ 
 
As seen above, we have more than one GAL4 driver for some subsets of glia. for 
example, we are using two different GAL4 drivers to target the expression of Rap/Fzr in 
Cortex glia. Although, both the GAL4 enhancer traps target the same subset of the glia, 
the tissue specific target differs in that Cortex glia is targeted by the presence of certain 
known gene or a particular sequence within the tissue of interest. Thus, NP2222 driver is 
placed upstream of (A-Kinase Anchoring Protein) Akap gene, which is located in the 
brain cortex, the same region where Cortex glia are expressed. NP577 is placed upstream 
of an unknown gene but a known sequence, which is also expressed, along with this same 
subset of glia in the cortex region of the brain.  
All the test groups were subjected to elevated temperatures and monitored for paralysis. 
The well-characterized TS paralytic mutant shibire
7068
/+ (shi) flies, which are 
characterized by the paralytic phenotype they exhibit at higher temperatures was used a 
positive control for the experiment. Wild-type flies, Canton-S flies and the respective 
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parental strain of each glia subset were used as the control groups to compare the 
difference in the paralytic phenotypes of the mutant flies, which overexpress Rap/Fzr in 
the glia subset dependent manner.  The difference between the control groups and 
experimental group was analyzed by ANOVA using the prism5 software (statistics 
shown in supplemental data).  From the statistical analysis, Repo-GAL4;733 UAS-
Rap/Fzr (Fig.7), NP3233; 733UAS-Rap/Fzr (Fig. 8), NP1243; 733 UAS-Rap/Fzr (Fig.9), 
and NP577; 733UAS-Rap/Fzr (Fig.10) genotypes showed a statistically significant 
difference in paralysis when compared to their respective control groups. 
NP3233;733 UAS-rap/fzr and NP124;733 UAS-rap/fzr are two different GAL4 
drivers for the astrocyte-like glia. NP3233; 733 UAS-rap/fzr mutant flies displayed severe 
paralysis when shifted into higher temperatures (Fig. 8). Paralysis was reversible upon 
return to 23
o
C.  The extent of paralysis increased with age, degree of temperature 
increase and duration spent at the increased temperature. Over 50% of the flies of the 
genotype  w [*]/+; P{w[+mW.hs]=GawB} NP3233/+;733 UAS-fzr/+ (expression of 
rap/fzr in astrocyte-like glia driven by NP3233) showed paralysis after first week of 
eclosion. The percent paralysis increased to 70, 73, 93 and 100 following 2, 3, 4 and 5 
weeks after eclosion respectively. The sample sizes tested for NP3233/733UAS-Rap/fzr at 
weeks 1, 2, 3, 4, 5 are 67, 56, 52, 43 and 23 respectively (Fig. 8). We also tested for 
paralysis at 32
 o
C to determine the stress threshold needed for paralysis to occur. At 32
 o
C 
flies show some paralysis however, the difference in the control and experimental groups 
is not significant (data not shown). When subjected to 28
o
C water baths, flies of all 
genotypes show no paralytic effect (data not shown). 
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Flies of the strain w[*]/+; P{w[+mW.hs]=GawB}wun[NP1243] / +; 733 UAS-fzr 
/+(expression of rap/fzr in astrocyte-like glia driven by NP1243) mutant flies displayed 
paralysis which is also statistically significantly different from the parental strain and 
Canton-S (Fig.9 ). However, the severity of the paralysis is less when compared to the 
flies of the genotype w [*]/+; P{w[+mW.hs]=GawB} NP3233/+;733 UAS-fzr/+ 
(expression of rap/fzr in astrocyte-like glia driven by NP3233). The percent paralysis 
exhibited by these flies increases slightly with age as the 2 weeks old flies show 36 % 
paralysis compared to the 6 weeks old flies which exhibit 42 % paralysis. These mutants 
exhibit very little paralysis when exposed to lower temperature of 32
 o
C and no effect at 
23
o
C (data not shown).   
Adult flies of the genotype w[*] P{w[+mW.hs]=GawB}NP0577 / +; +/+;733 UAS-
rap/fzr /+ , which encodes the expression of rap/fzr in cortex glia also show statistically 
significant difference among the three groups tested (parental and wild-type) (Fig.10). 
The percent paralysis increases from 20 % to 56 % from 1week old to 5 weeks old flies, 
and indication of age-dependence paralysis.   
Flies of the genotype w[*]/+;P{w[+mW.hs]=GawB}Akap200[NP2222]/+;733 UAS-
rap/fzr /+, which also encodes the expression of rap/fzr in cortex glia targeted by NP2222 
show slight paralysis. However, the fraction of the mutant flies paralyzed is not 
significantly different from their respective control groups (Fig. 11). Other subsets 
expressing Rap/Fzr also do not show a significant difference in the paralytic phenotype 
exhibited by the control groups (Fig. 12, 13, 14).  
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Several experiments were performed to determine that it was the overexpression of 
rap/fzr, which was causing the paralytic phenotypes. Such as, in an experiment, we 
overexpressed a different subunit of the APC/C, APC2 in pan glia to determine that it 
was the Rap/Fzr/Cdh1 was the only regulatory unit of the anaphase promoting complex 
which causes neurodegenerative phenotypes.  APC2 is a cullin homology subunit of 
APC/C, an E3 ubiquitin ligase.  The mutant flies exhibiting, pan-glia driven 
overexpression of the APC2 failed to show temperature-sensitive paralysis (Fig.15). 
There observed difference of the fraction paralyzed between the mutant and control flies 
is not statistically significant.   
In addition, we also tested to see the specificity of the E3 ubquitin ligase, APC/C, itself in 
its role in regulating the paralytic behavior phenotype, which is one of the indicators of 
neurodegeneration. Thus, we tested a different E3 ubiquitin ligase called Highwire. 
Highwire is a protein that regulates synaptic growth and transmission at the Drosophila 
neuromuscular junction. Flies showing pan-glia driven over-expression of UAS-Highwire 
does not show an increase in paralysis (Fig.16). Thus, this study determined that proper 
regulation of the specific E3 ubiquitin ligase, APC/C is important in proper neuronal 
maintenance.  We also wanted to test whether overexpression of rap/fzr in neurons would 
leads to any behavioral changes. We used a neuronal driver called Embryonic Lethal 
Abnormal Vision system (ELAV), which encodes an RNA binding expressed in all 
neurons after birth and expressed rap/fzr. These mutants also did not exhibit paralysis 
(Fig.17).  
The Temperature-Sensitive paralysis data indicate that targeted expression of rap/fzr in 
glia subsets results induces paralysis in the flies at 37
 o
C.  Among the flies tested for this 
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phenotype, astrocyte-like glia driven overexpression on rap/fzr, and one GAL4 driver of 
the cortex glia driven overexpression of rap/fzr show paralytic phenotype. Thus, this 
allows us to test these mutant flies for other assays that are indicative of 
neurodegeneration.  
 
















Figure7: Expression of Rap/Fzr in panglia (all glia in CNS except  midline glia) driven by the Repo-GAL4 driver 
shows an age-dependent paralytic behavior phenotype. Flies were tested for paralysis upon eclosion, and at the ages of 
1,2,3 and 4 weeks old. At birth and the ages of 1, 2 and 3 weeks old, 5%, 5%, 20% and 30% flies showed paralytic 
phenotype respectively. At the age of 4 weeks of old, 70% flies exhibit immediate paralysis, whereas upon longer 
exposer (8 minutes) to higher temperature of 38°C, 100% flies show paralysis. The experimental group shows similar 
paralytic phenotype at the 4 weeks of age as compared to the positive control group, which is Shibire7068 (a paralytic 
mutant). The negative control group, which is UAS-Rap/Fzr, shows very slight paralysis at the age of 4 weeks old. (this 
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  NP3233 (Astrocyte-like glia) targeted expression of Rap/Fzr



























Figure 8: Expression of Rap/Fzr in astrocyte-like glia driven by the NP3233 GAL4 driver shows an age-dependent 
paralytic behavior phenotype. Flies were tested for paralysis upon eclosion, and at the ages of 1,2,3,4 and 5 weeks old. 
At birth and the ages of 1, 2, 3, 4 and 5 weeks old, 0%, 52%, 69%, 72%, 92% and 100% flies showed an immediate 
paralytic phenotype respectively. The negative control groups- Canton S and the parental strain, NP 3233 (astrocyte-
like glia) does not show the paralytic phenotypes. The sample sizes used for different groups were Cs -17- 90,  
NP3233/UAS-Rap/Fzr- 23- 67, NP3233- 8 -89. 
           NP1243(Astrocyte-like glia) targeted expression of Rap/Fzr






























Figure 9: Expression of Rap/Fzr in astrocyte-like glia driven by the NP1243 GAL4 driver shows slight paralysis in 
adult flies. Flies were tested for paralysis upon eclosion and after every 7days until death. Percent paralysis exhibited 
by the experimental group was higher than the control groups for first few weeks (week1, 2, 3, 4 show 16%, 36%, 29% 
36%paralysis compared with  0% paralysis of the control group at week 4). The negative control groups- Canton S and 
the parental strain, NP 1243(astrocyte-like glia) does not show the paralytic phenotypes. The sample sizes used for 
different groups were Cs -17- 90, NP1243/733 UAS-Rap/Fzr - 25-90, NP1243 - 33-90. 
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NP577 (Cortex glia) targeted expression of Rap/Fzr










0577 / +; +/+;733
UAS-rap/fzr /+
w[*];P{w[+mW.hs]=GawB}
















Figure 10: Expression of Rap/Fzr in cortex glia driven by the NP 577 GAL4 driver shows an age-dependent paralytic 
behavior phenotype. Flies were tested for paralysis upon eclosion and every 7 days until death. Percent paralysis 
exhibited by the experimental group was higher than the control groups for first 8 weeks (at week1, 4, 7 show 20%, 
42%, 56% flies show paralysis compared with 0%, 3% 20% flies exhibiting paralysis of the Canton-S control group). 
The sample sizes used for different groups were Cs -17- 90, NP577/733 UAS-Rap/Fzr –30-114, NP577 – 21-72. 
 
NP2222 (Cortex glia) targeted expression of Rap/Fzr






























Figure 11: Expression of Rap/Fzr in cortex glia driven by the NP 2222 GAL4 driver does not show a paralytic behavior 
phenotype. Flies were tested for paralysis upon eclosion and every 7 days until death. The experimental and control 
groups show similar, low percent paralysis in the respective flies. The sample sizes used for different groups were Cs -
17- 90, NP2222/733 UAS-Rap/Fzr - 12-60, NP2222 – 31-50. 
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NP6293 (Perineural glia) targeted expression of Rap/Fzr





























Figure 12: Expression of Rap/Fzr in perineural driven by the NP 6293 GAL4 driver does not show a paralytic behavior 
phenotype. Flies were tested for paralysis upon eclosion and every 7 days until death. The experimental and control 
groups show similar, low percent paralysis in the respective flies. The sample sizes used for different groups were Cs -
17- 90, NP6293/733 UAS-Rap/Fzr – 29-80, NP6293 – 29-85. 
 
Figure 13: Expression of Rap/Fzr in ensheathing glia driven by the NP6520 GAL4 driver does not show paralytic 
NP6520 (Ensheathing glia) targeted expression of Rap/Fzr































behavior phenotype in adult flies. Flies were tested for paralysis upon eclosion and every 7 days until death. The 
experimental and control groups show similar, low percent paralysis in the respective flies. The sample sizes used for 
different groups were Cs -17- 90, NP6520/733 UAS-Rap/Fzr – 13-90, NP6520 – 19-86.  
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NP2276 (sub-perineural glia) targeted expression of Rap/Fzr





























Figure 14 Expression of Rap/Fzr in subperineural driven by the NP 2276 GAL4 driver does not show a statistically 
significantly paralytic behavior phenotype. Flies were tested for paralysis upon eclosion and every 7 days until death. 
The experimental and control groups show similar, low percent paralysis in the respective flies. The sample sizes used 
for different groups were Cs -17- 90, NP2276/733 UAS-Rap/Fzr – 52-90, NP2276 - 13- 65. 
 
Panglia targeted expression of APC2
























Figure 15 Panglia targeted expression of APC2 does not show paralytic behavior phenotype in adult flies. Flies were 
tested for paralysis upon eclosion and every 7 days until death. The experimental and control groups show similar, low 
percent paralysis in the respective flies. The sample sizes used for different groups were Cs -17- 90, Repo/APC2 – 34-
90, UAS-APC2 – 5-96. 
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Repo-Gal4/UAS-Hiwire

























gure 16Panglia targeted expression of Highwire does not show paralytic behavior phenotype in adult flies. Flies were 
tested for paralysis upon eclosion and every 7 days until death. The experimental and control groups show similar, low 
percent paralysis in the respective flies. The sample sizes used for different groups were Cs -17- 90, Repo/Highwire- 
45- 90, UAS Highwire/Cyo- 23-67.  
Experssion of Rap/Fzr in neurons

























Figure 17 Neuronal driven overexpression of rap/fzr does not show paralytic behavior phenotype in adult flies. Flies 
were tested for paralysis upon eclosion and every 7 days until death. The experimental and control groups show similar, 
low percent paralysis in the respective flies. The sample sizes used for different groups were Cs -17- 90, 
ElavGal4/UAS-Rap/Fzr- 35-70, Elav Gal4- 17- 53. 
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Glia targeted expression of Rap/Fzr leads to reduced lifespan: 
Pathological studies on human brains have shown that volume and weight of the brain 
decline with age at a rate of about 5% every 10 years after the age of 40 (Shankar 2010). 
Furthermore it has also been reported that in aged non-human primates, there is a 30% 
reduction in neuronal number in prefrontal cortex along with an increased sub-cortical 
white matter lesions (WML) (Shankar 2010). The compromised nervous system of the 
individuals presumably leads to early death in several neurodegenerative diseases like 
Parkinson‟s disease and Alzheimer‟s disease. Thus, the association of neurodegeneration 
with an aging population allows scientists to use „alteration in life span‟ as an indicator of 
neurodegeneration. Previous studies in our laboratory have shown that gain-of-function 
mutants of rap/fzr result show fewer glia in the CNS of the 3
rd
 instar larva of Drosophila 
(Kaplow, Korayem et al. 2008). These mutant flies also exhibit a decreased life span. 
Adult flies overexpressing rap/fzr in panglia specific manner, results in an about 45% 
reduction in life span along with a 100% paralysis at the age of 4 weeks (Fig.18).  These 
findings suggest the important role of rap/fzr in maintaining neuronal integrity by 
regulating glia differentiation. To further understand the role of glia during 
neurodegeneration and lifespan shortening, we sought to assess the contribution of 
specific glia subtypes. To do this, we assayed the life span of all the fly strains expressing 
UAS-rap/fzr in the various glia subtypes (see table 2). All of the gain-of-function mutant 
flies of different subtypes of glia were monitored for life span alterations. Among the 
subsets tested, astrocyte-like glia subset over-expressing rap/fzr shows a significantly 
shorter lifespan (Fig. 19). One week after eclosion, astrocyte-like glia (NP3233/733UAS-
Rap/fzr) showed a 67% (n tested = 309) survival compared to 96% of CS (n=219) and 
93% of NP3233 (n=188). Three weeks after eclosion the same mutant flies exhibit 23% 
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survival compared to 83 % and 70% of the CS and NP3233 parental flies. There is a 
1.5% survival of astrocyte-like glia compared with 67% CS and 64 %NP3233. All flies 
were dead within 38 days of eclosion.  
Expression of rap/fzr in other subsets of glia, also showed a slight alteration in life span, 
however statistical analysis of data , did not show that these mutant life spans were 
significantly different when compared to their parental strain and the wild-type flies 
Canton-S . Flies which express rap/fzr in cortex glia targeted by NP2222, show an 
increase in life span by 1 week when compared with their parental strain and 2 weeks less 
than the wild type, Canton-S flies (Fig. 21). However, the difference among these groups 
is not statistically significant enough to propose that overexpression of rap/fzr has an 
important effect in life span of these flies. Although, flies which express rap/fzr in cortex 
glia targeted by NP577 show a statistically significant paralytic phenotype, these flies fail 
to show any alterations in the lifespan of the flies as both the parental strain and the 
experimental group die by 10 weeks (Fig. 22). Flies expressing rap/fzr in ensheathing glia 
also show no alterations in their life span, as both parental and the experimental flies both 
die by 11 weeks (Fig 24. Mutant flies expressing rap/fzr in both perineural glia and 
Subperineural glia do not show significant alterations in their life spans (Fig.23 and 
Fig.25). Mutant flies which express panglia targeted expression of APC2 does not show 
significant reduction in life span as the mutants live 11 weeks compared to the 12 weeks 
of the control flies (Fig 26). Flies of the genotype, repo-Gal4;UAS-Highwire (panglia 
driven overexpression of Highwire) live as long as the parental stain and it is  slightly less 
than the Canton-S flies (Fig. 27). Elav-Gal4;733UAS-Rap/fzr (neuronal driven 
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overexpression of rap/fzr) flies live as long as the wild type flies (12 weeks) hence, shows 
no apparent change in life span alteration (Fig. 28).  
Thus, statistical analysis of the lifespan assay of all the genotypes does not provide a 
statistically significant difference between the mutant and control flies of all the strains 
mentioned above except for astrocyte-like glia. Thus, reduced life span correlates also 
with the increased paralysis in these flies, showing a promising involvement of astrocyte-
like glia in neuroprotection and neurodegeneration.  
Effects of glia targeted expression of Rap/Fzr on Life span reduction 
 






Figure 18: Expression of Rap/Fzr in panglia (all glia in CNS except midline glia) driven by the Repo-GAL4 driver 
shows reduction in maximum life span when compared to the control groups of Canton-S and UAS-Rap/Fzr. The 
experimental group lives at maximum, 5 weeks in age compared with 9 1/2 weeks of the UAS-Rap/Fzr  control group 
and 11 weeks of the Canton-S control group(this experiment was performed by Rosa Mino) 
 Repo-Gal4/UAS-Rap/Fzr (pan glia) targeted expression of Rap/Fzr leads to 
maximum life span reduction 
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                         NP3233 (Astrocyte-like glia) targeted expression of Rap/Fzr leads to
maximum life span reduction

























Figure 19: Expression of Rap/Fzr in astrocyte-like glia driven by the NP3233 driver show reduction in maximum life 
span.  Among the 309 flies tested flies of the astrocyte-like glia expressing Rap/Fzr flies, only1.5% survive by the age 
of 5 weeks old. By 38 days post eclosion, there is a 0% survival in this group of flies, which is statistically significantly 
different from the control groups. The control groups tested for this experiment was the parental strain (NP3233) and 
Canton-S. The control groups show 0% survival at the ages of 9 1/2weeks (NP3233) and 12 weeks (Canton-S). The 
difference among the three groups is statistically significant. 
                NP1243(Astrocyte-like glia) targeted expression of Rap/Fzr


























Figure 20: Expression of Rap/Fzr in astrocyte-like glia driven by the NP1243 driver does not cause a reduction in 
maximum life span. The parental and the mutant flies die at 11 weeks and the wildtype, Canton-S dies at 12 weeks. The 
difference in these groups is not statistically significant.  
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NP2222 (Cortex glia) targeted expression of Rap/Fzr
























Figure 21: The experimental group expressing Rap/Fzr in cortex glia driven by the NP 2222 driver does not cause a 
statistically significant decrease in maximum lifespan when compared with the control groups. The parental group and 
the experimental group, have same maximum life span of10 weeks. The sample sizes tested for the three groups are 
219, 152, and 63 for Canton-S, NP2222/UAS- Rap/Fzr, and parental NP 2222 respectively. This difference in the three 
groups survival curves is not statistically significant.  
NP577 (Cortex glia) targeted expression of Rap/Fzr



























Figure 22: Group exhibiting the expression of Rap/Fzr in cortex glia driven by the NP577 driver does not cause a 
statistically significant decrease in maximum lifespan when compared with the control groups both, NP577 and the 
wildtype, Canton-S. The sample size tested for the three groups are 219, 315, and 99 for Canton-S, NP577/UAS- 
Rap/Fzr, and parental NP 577 respectively. This difference in the three groups survival curves is not statistically 
significant.  
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NP6293 (Perineural glia) targeted expression of Rap/Fzr





























Figure 23: Group exhibiting the expression of Rap/Fzr in perineural glia driven by the NP6293 driver does not cause a 
statistically significant decrease in maximum lifespan when compared with the control groups both, NP6293 and the 
wildtype, Canton-S. The sample size tested for the three groups are 219, 331, and 199 for Canton-S, NP6293/UAS- 
Rap/Fzr, and parental NP 6293 respectively. This difference in the three groups survival curves is not statistically 
significant. 
     NP6520 (Ensheathing glia) targeted expression of Rap/Fzr



























Figure 24: The experimental group exhibiting the expression of Rap/Fzr in ensheathing glia driven by the NP6520 
driver does not cause a statistically significant decrease in maximum lifespan when compared with the control groups 
both, NP6520 and the wildtype, Canton-S. The sample size tested for the three groups are 219, 631, and 134 for 
Canton-S, NP6520/UAS- Rap/Fzr, and parental NP 6520 respectively. This difference in the three groups survival 
curves is not statistically significant.  
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      NP2276 (sub-perineural glia) targeted expression of Rap/Fzr


























Figure 25: The experimental group exhibiting the expression of Rap/Fzr in subperineural glia driven by the NP2276 
driver does not cause a statistically significant decrease in maximum lifespan when compared with the control groups 
both, NP2276 and the wildtype, Canton-S. The parental strain and the mutant strain have 0% survival at the same time 
(11 weeks). The sample size tested for the three groups are 219, 352, and 73 for Canton-S, NP2276/UAS- Rap/Fzr, and 
parental NP 2276 respectively. This difference in the three groups survival curves is not statistically significant.  
Panglia targeted expression of APC2
























Figure 26: The experimental group exhibiting the expression APC2 of  in pan glia (all glia except midline glia) driven 
by the Repo gal4 driver does not cause a statistically significant decrease in maximum lifespan when compared with 
the control groups both, UAS-APC2 and the wildtype, Canton-S. The parental strain and the wildtype, Canton-S have a 
0% survival by the age of 12 weeks. Whereas, the experimental group have a maximum life span of 11 weeks. 
However the difference in the three groups survival curves is not statistically significant. The sample size tested for the 
three groups are 219, 117, and 60 for Canton-S, Repo-GAL4/APC2, and parental APC2 respectively.  




























Figure 27 The experimental group exhibiting the expression of Highwire in pan glia (all glia except midline glia) 
driven by the Repo gal4 driver does not cause a decrease in maximum lifespan when compared with the control groups 
both, UAS-Highwire/Cyo and the wildtype, Canton-S. The experimental strain and the control, parental strain a 0% 
survival by the age of 12 weeks. The difference in the three groups survival curves is not statistically significant. The 
sample size tested for the three groups are 219, 122, and 50 for Canton-S, Repo-GAL4/UAS-Highwire, and parental 
UAS-Highwire/Cyo respectively. 
Experssion of Rap/Fzr in neurons





















Figure 28: Expression of Rap/Fzr in neurons driven by the Elav-Gal4 driver does not cause a statistically significant 
decrease in maximum lifespan when compared with the control groups both, Elav-GAL4/UAS-Rap/Fzr and the 
wildtype, Canton-S. All three groups tested have a maximum life span of 12 weeks. The sample size tested for the three 
groups are 219, 149, and 60 for Canton-S, Elav-GAL4/UAS-Rap/Fzr, and parental Elav-GAL4 respectively. 
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Glia targeted expression of Rap/Fzr leads to vacuolization in the brain tissue: 
In Drosophila, the anatomical hallmark of neurodegeneration is the appearance of 
vacuole-like lesions in the brain that become more pronounced with age (Buchanan and 
Benzer 1993; Min and Benzer 1997; Gnerer, Kreber et al. 2006).  Vacuoles may be 
diffuse or localized to specific structures within the CNS.  Toluidine blue staining reveals 
that, in addition to temperature-sensitive paralysis and reduced life-span, rap/fzr gain-of-
function mutants show vacuolization of brain tissues characteristic of progressive 
neurodegeneration (Fig. 29c). The figure presents different mutants flies with their 
corresponding control (parental strain) on their right. As we can observe by looking at 
each panel that among all the subset mutants, that only NP3233/733-UAS Ra/Fzr shows 
vacuolization in the optic lobe region of the brain. NP3233/733-UAS Ra/Fzr genotype is 
showing overexpression of rap/fzr in astrocyte-like glia specific manner. Additional 
images are provided to illustrate the extent of vacuolization in the brain tissue of these 
mutants (Fig. 30, Fig.31). Figure 30 focuses on the optic lobe region of the brain whereas, 
Figure 31 illustrates the striation and vacuolization in the cortex region of the brain of 
these flies which is the possible missing brain tissue.  
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Figure 29: Adult brain 4 weeks old 1μ thick sections stained with 10% toluidine blue dye. Vacuolization is observed in 
the lamina and medulla regions of the brains of flies expressing Rap/Fzr in panglia driven by Repo-GAL4 (c) and in 
astrocyte-like glia driven by NP3233 (e). The parental strains of each experimental group, Canton-S, and UAS-Rap/Fzr 
flies exhibit no vacuolization in the brain.  




Figure 30: Expression of Rap/Fzr in astrocyte-like glia driven by the NP3233 driver induces holes induces holes in the 
lamina and medulla regions of the 4 week old brains. For control groups please refer to fig. 29a,b and f. The brains are 
sectioned with 1μ thickness and stained with 10 % toluidine blue dye.  
 
 
Figure 31: Expression of Rap/Fzr in astrocyte-like glia driven by the NP3233 driver induces holes in the midbrain 
region of the CNS (fig 31 a-c). fig 10d is the section of the midbrain region of the 733 UAS-fzr, and serves as a control 









The present research was undertaken to test the gain-of-function phenotypes following 
glia subset specific overexpression of rap/fzr. Flies exhibiting astrocyte-like glia driven 
over expression of rap/fzr show reduction in maximum life span, severe age-dependent 
paralysis and vacuolization in their brain tissue. The macromolecules composing neural 
structures are constructed according to genetic information and are thus subject to 
modification by mutation. In analyzing the basic mechanisms in neurophysiology, 
mutations affecting specific neural elements are potentially insightful(Loughney, Kreber 
et al. 1989). Due to close involvement of glia in maintaining neuronal integrity, 
behavioral assays following mutations affecting glia development are promising tools to 
study the neurophysiology. Alteration of genes responsible for the synthesis of membrane 
components, transmitter molecules or protein structures could be employed to disturb 
axonal conduction, synaptic transmission or muscle responses(Pfrieger and Barres 1995). 
Genetic modification or loss of specific membrane molecules, regulators of cell-cycle 
signaling and development could alter the functions of various neurons, synapses or 
muscles to different degrees. To define the physiological roles of specific glia specific 
proteins in neuronal function and maintenance, we focused on Drosophila mutants 
exhibiting rapid TS paralysis, reduced life span and vacuolization in the CNS.  
Analyses of rap/fzr gain-of-function mutants reveal a number of observable phenotypes 
result from possible the loss of glia. Similar loss of blood-brain barrier integrity is 
observed in loco
∆13
 mutants, where the disruption of glia differentiation caused by loss of 
loco also results in embryonic lethality (Granderath, Bunse et al. 2000; Schwabe, Bainton 
et al. 2005).loco mutant embryos initially exhibit normal glia development and 
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replication, but ultimately fail to make glia-glia contacts necessary for axon ensheathment 
and blood-brain barrier formation (Granderath, Bunse et al. 2000; Schwabe, Bainton et al. 
2005). Kaplow, et al. (2007), showed that Loco and Rap/Fzr physically interact in tissue 
extracts and co-localize in larval CNS (Kaplow, Mannava et al. 2007). Surface glia form 
glia-glia septate junctions essential to the establishment and function of the blood-brain 
barrier (Carlson, Juang et al. 2000; Schwabe, Bainton et al. 2005; Stork, Engelen et al. 
2008). Partial loss of Loco due to overexpression of rap/fzr during development leads to 
failure of surface glia differentiation and blood-brain barrier disruption consistent with 
loco mutants(Yu, Wang et al. 2005). 
Embryonic lethality of loco and other mutants effecting blood-brain barrier integrity has 
prevented investigation of phenotypes that may arise later in development (Granderath, 
Stollewerk et al. 1999; Bainton, Tsai et al. 2005).  Glia-specific rap/fzr overexpression 
yields a workable model for the consequences of blood-brain barrier integrity defects, 
and improper ensheathment of neurons in adult flies.  
There are number of different Drosophila glia subtypes that have been characterized 
based on location and morphology which includes the cortex, perineurial, subperineurial, 
ensheathing glia and astrocyte-like glia. Insects have an open circulatory system thus; 
they need a blood brain barrier to protect their CNS from hemolymph. Surface glia come 
together and forms a single- layer epithelium with septate junctions late in development. 
Perineural and subperineurial glia has been shown to function in the Blood brain barrier 
(BBB) of the adult flies. Peripheral glia help shield axons against the high potassium 
concentration of the hemolymph, which if exposed to the neuron would obstruct their 
resting and action potentials. Cortex glia enwrap many neuronal cell bodies. Neuropile 
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glia, which is composed of ensheathing and astrocyte-like glia extend their sheath-like 
membranes around axon bundles. They help isolate nerves and promote neuronal survival 
through trophic support. Ensheathing glia are presumed to perform phagocytic activities 
after neuronal death. Astrocytic glia are required for the clearance of excess 
neurotransmitters at the synaptic cleft and are responsible for modulating synapse 
formation and signaling. Astrocyte glia are also involved in the clearance of potassium 
which along with glucose regulation increases extracellular space as well as promotes 
synaptic activation. While pan-glia driven overexpression of rap/fzr mutants eclose 
normally, they show a drastic lifespan reduction, increased paralysis and brain 
vacuolization indicative of neurodegeneration. The next step for us to do was to identify 
the major subtypes of glia, which are affected by the over-expression of rap/fzr. From our 
results, we have been able to obtain preliminary data indicating that astrocyte-like glia 
play a crucial role in neurodegeneration. Astrocyte-like glia driven over expression of 
rap/fzr shows an early death phenotype with life span, half of the control groups. These 
flies also show severe and age-dependent paralytic phenotypes at higher temperatures, 
indicating that there is loss of activity of certain proteins involved in rap/fzr signaling. 
Toulidine blue staining of the brain of these flies at the age of 4 week after eclosion, also 
show missing brain tissue/vacuolization though the adult Drosophila brain. 
The reduced lifespan phenotype has been successfully utilized to screen for mutations 
causing neurodegeneration (Buchanan and Benzer 1993; Kretzschmar, Hasan et al. 1997; 
Min and Benzer 1997). The mutants spongecake and eggroll, chosen on the basis of 
decreased survival time, exhibit age-dependent neurodegeneration but normal glia 
development (Min and Benzer 1997). Other lifespan mutants, however, do exhibit glia 
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defects in conjunction with vacuolization of the CNS typical of neurodegeneration.  The 
mutant swiss cheese causes glia hyperwrapping resulting in neuronal death (Kretzschmar, 
Hasan et al. 1997; Kretzschmar, Poeck et al. 2000). Cortex glia in drop-dead mutants 
fails to extend processes or properly enwrap neuronal cell bodies leading to 
neurodegeneration and greatly reduced lifespan (Buchanan and Benzer 1993). 
Flies exhibiting paralysis at elevated temperatures carry mutations in proteins of vastly 
different distribution and function.  It has been shown that the temperature-sensitive 
phenotype is not due to the thermolability of the mutated protein itself, but rather the loss 
of the mutated protein leads to nervous system disruptions resulting in the inability of the 
nervous system to withstand the added stress of higher, or in some instances lower, 
temperatures (Loughney, Kreber et al. 1989; Atkinson, Robertson et al. 1991; Titus, 
Warmke et al. 1997; Coyle, Koh et al. 2004). Glia-specific overexpression of rap/fzr, an 
activator of a ubiquitin E3 ligase, perhaps leads to the partial loss of many proteins 
ranging in function from cell cycle progression to signal transduction and transcription 
regulation (Kaplow, Mannava et al. 2007; Kaplow, Korayem et al. 2008)which may 
result in the breakdown of nervous system integrity at higher temperatures.   
Previously, APC2, a cullin homology subunit of the APC, generated temperature-
sensitive loss-of-function alleles that showed cell cycle arrest at the restrictive 
temperature(Kammerer and Giangrande 2001). However, APC2 gain-of-function flies 
failed to show temperature-sensitive paralysis and did not show a decrease in life span. 
The precise role of APC2 in nervous system development remains to be defined in future 
experiments. However, its use in the experiments as a controls, emphasizes that 
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misregulation of the 9
th
 subunit of the APC (Rap/fzr) has a potential role in onset of 
neurodegeneration.  
UAS-Highwire was used as a control to test for the specificity of rap/fzr in producing the 
neurodegenerative phenotype that it does. UAS-Highwire is an E3 ubiquitin ligase, which 
negatively regulates BMP signaling at the NMJ. Pan-glia driven over-expression of UAS-
Highwire shows no dramatic decrease in life span, nor does it show any increase in 
paralysis and neither is any vacuolization observed in the brain (data not shown).  
Embryonic Lethal Abnormal Vision system (ELAV) encodes an RNA binding expressed 
in all neurons after birth which makes ELAV a pan-neural gene. To test to see if the 
neurodegenerative phenotypic effects of rap/fzr are glia specific, we carried out the 
neuron specific elav driven over-expression of UAS-Fzr was conducted. The results show 
no ill effects and are similar to the control groups and thus, strengthen the role of rap/fzr 
as an activator of ubiquitin ligase causing partial loss of many proteins which possibly 
regulate glia differentiation. 
Glia-specific overexpression of rap/fzr, an activator of a ubiquitin ligase, certainly leads 
to the partial loss of many proteins ranging in function from cell cycle progression to 
signal transduction and transcription regulation (Kaplow, Mannava et al. 2007)which 
may result in the breakdown of nervous system integrity at higher temperatures.  From 
the above results it is indicative that the misregulation of astrocyte-like glia in rap/fzr 
gain-of-function mutants leads reduced life span, paralysis and vacuolization in the brain.  
Astrocyte-like glia display a dendritic morphology and are present within the neuropils in 
the CNS. Due to the interactions of astrocyte-like glia with multiple neurons, their 
presumed function is to provide trophic support to the neuron, ensheath neuron and 
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maintain a homeostatic balance for the neurons (Freeman and Doherty 2006). Based on 
its location and morphology, the presumed functional roles of the astrocyte-like glia are 
analogues to astrocyte glia and oligodendrocytes of the vertebrates.  In mammals, 
oligodendrocytes are known to provide support to axons and to produce the Myelin 
sheath. Oligodendrocytes wrap the myelin around the axons. Myelin sheath allows for the 
efficient conduction of action potentials down the axon. Disruption or inactivation of the 
oligodendrocytes presents some of the neuropathological deficits associated with 
neurodegenerative diseases such as schizophrenia, multiple sclerosis and Alzheimer‟s 
disease.  
Now that we have narrowed the subset of glia, which seems to be more essential for 
proper neuronal functioning, we can propose that neurodegeneration followed by the 
disruption of astrocyte-like glia undergoes similar to the currently unknown cellular 
mechanisms as demyelination associated diseases in humans (such as multiple sclerosis). 
To further our research we will try to gain insights into the mechanisms of 
neurodegeneration. Astrocyte-like glia (NP3233) is the major subtype of glia that is 
affected by the activation of APC/C of glia-essential components of development and 
glia-essential components of neuroprotection. Next step to identify the genes that 
suppress Rap/Fzr mediated neurodegeneration.  These genes may help us further 
understand the mechanisms of neurodegeneration and life span shortening as well as act 
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Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.0296     
P value summary *     
Are means significantly. different? (P < 0.05) Yes     
Number of groups 3     
F 4.118     
R square 0.2637     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.9160     
P value 0.6326     
P value summary ns     
Do the variances differ significantly. (P < 
0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.8054 2 0.4027 
Residual (within columns) 2.249 23 0.09779 
Total 3.054 25   
 
 
Age in weeks CS NP3233/733 NP3233  
 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 67 0.000000 0.000000 89 
1. 0.014286 0.034993 75 0.528704 0.361861 67 0.023958 0.047022 89 
2. 0.014286 0.034993 78 0.694388 0.237824 56 0.000000 0.000000 72 
3. 0.028571 0.069985 75 0.727891 0.276018 52 0.111905 0.186764 70 
4. 0.033333 0.053452 90 0.922619 0.145194 43 0.161905 0.228058 76 
5. 0.140000 0.149666 60 1.000000 0.000000 23 0.215285 0.229531 68 
6. 0.156777 0.117569 85       0.470619 0.301298 54 
7. 0.204365 0.110626 60       0.569444 0.165468 39 
8. 0.457522 0.176475 53       0.800000 0.188562 27 
9. 0.790476 0.175093 17       0.900000 0.141421 8 










CS NP1243/733 UAS-Fzr NP1243  
 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 90 0.000000 0.000000 90 
1. 0.014286 0.034993 75 0.162698 0.111677 90 0.000000 0.000000 90 
2. 0.014286 0.034993 78 0.364469 0.210739 60 0.000000 0.000000 75 
3. 0.028571 0.069985 75 0.297024 0.343104 55 0.026786 0.075761 76 
4. 0.033333 0.053452 90 0.365344 0.339171 39 0.000000 0.000000 65 
5. 0.140000 0.149666 60 0.368182 0.364645 33 0.000000 0.000000 51 
6. 0.156777 0.117569 85 0.424127 0.342648 36 0.131066 0.130567 64 
7. 0.204365 0.110626 60 0.473993 0.301449 50 0.122222 0.122572 54 
8. 0.457522 0.176475 53 0.515079 0.349324 45 0.190883 0.240888 33 
































Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.0052     
P value summary **     
Are means significantly. different? (P < 0.05) Yes     
Number of groups 3     
F 6.475     
R square 0.3325     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 9.586     
P value 0.0083     
P value summary **     
Do the variances differ significantly. (P < 0.05) Yes     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.4703 2 0.2352 
Residual (within columns) 0.9442 26 0.03632 
Total 1.415 28   
Age in 
weeks 
CS NP577/733 UAS-Fzr NP577 
 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 114 0.000000 0.000000 68 
1. 0.014286 0.034993 75 0.200427 0.135486 114 0.000000 0.000000 68 
2. 0.014286 0.034993 78 0.252244 0.168100 99 0.018519 0.045361 64 
3. 0.028571 0.069985 75 0.350476 0.250524 99 0.011111 0.027217 67 
4. 0.033333 0.053452 90 0.426905 0.342285 77 0.025641 0.062807 72 
5. 0.140000 0.149666 60 0.569903 0.332047 71 0.083333 0.132916 60 
6. 0.156777 0.117569 85 0.565238 0.319533 65 0.172619 0.207532 60 
7. 0.204365 0.110626 60 0.566565 0.356836 59 0.341667 0.380606 55 
8. 0.457522 0.176475 53 0.647619 0.314042 40 0.361111 0.427092 37 
9. 0.790476 0.175093 17 0.837500 0.229172 30 0.333333 0.577350 21 
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Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.0102     
P value summary *     
Are means significantly. different? (P < 0.05) Yes     
Number of groups 3     
F 5.5     
R square 0.29     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 2.3     
P value 0.3092     
P value summary ns     
Do the variances differ significantly. (P < 0.05) No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.54 2 0.27 
Residual (within columns) 1.3 27 0.050 
Total 1.9 29   




d) NP2222/733 UAS Fzr 
 
age in weeks CS NP2222/733 UAS Fzr NP2222  
 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 50 0.000000 0.000000 42 
1. 0.014286 0.034993 75 0.066667 0.049065 50 0.000000 0.000000 42 
2. 0.014286 0.034993 78 0.105238 0.074124 40 0.000000 0.000000 40 
3. 0.028571 0.069985 75 0.088265 0.139342 60 0.050000 0.057735 42 
4. 0.033333 0.053452 90 0.119444 0.158674 50 0.076190 0.056745 50 
5. 0.140000 0.149666 60 0.129365 0.209760 48 0.082723 0.061370 50 
6. 0.156777 0.117569 85 0.232143 0.218893 40 0.114583 0.078874 38 
7. 0.204365 0.110626 60 0.268750 0.101008 25 0.104482 0.076075 32 
8. 0.457522 0.176475 53 0.283333 0.402078 23 0.182937 0.035145 31 
































Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.2910     
P value summary ns     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 1.295     
R square 0.09058     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 11.95     
P value 0.0025     
P value summary **     
Do the variances differ significantly. (P < 0.05) No     
    
    
    
ANOVA Table SS df MS 
Treatment (between columns) 0.09325 2 0.04663 
Residual (within columns) 0.9363 26 0.03601 
Total 1.030 28   
    












Parameter       
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.0214     
P value summary *     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 4.472     
R square 0.2559     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 14.14     
P value 0.0009     
P value summary ***     
Do the variances differ significantly. (P < 0.05) No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.3615 2 0.1807 
Residual (within columns) 1.051 26 0.04042 






Table Analyzed Data 1     
        
One-way analysis of variance       
age in  
weeks 




 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 90 0.000000 0.000000 65 
1. 0.014286 0.034993 75 0.082921 0.057958 90 0.000000 0.000000 65 
2. 0.014286 0.034993 78 0.108503 0.112585 65 0.000000 0.000000 56 
3. 0.028571 0.069985 75 0.223810 0.338137 82 0.000000 0.000000 52 
4. 0.033333 0.053452 90 0.307550 0.347568 80 0.061111 0.071233 44 
5. 0.140000 0.149666 60 0.332407 0.348918 70 0.018519 0.045361 46 
6. 0.156777 0.117569 85 0.410185 0.368221 61 0.066138 0.116390 45 
7. 0.204365 0.110626 60 0.463295 0.314139 55 0.091667 0.111430 50 
8. 0.457522 0.176475 53 0.591358 0.345776 53 0.154762 0.016836 13 
9. 0.790476 0.175093 17 0.677594 0.320263 52       
age in 
weeks 
CS NP6520/733 NP6520  
 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 82 0.000000 0.000000 86 
1. 0.014286 0.034993 75 0.019048 0.050395 82 0.019048 0.050395 86 
2. 0.014286 0.034993 78 0.030357 0.057366 90 0.030357 0.057366 82 
3. 0.028571 0.069985 75 0.068027 0.128534 84 0.068027 0.128534 85 
4. 0.033333 0.053452 90 0.072619 0.142290 80 0.060714 0.115341 79 
5. 0.140000 0.149666 60 0.1388048 0.160880 62 0.119048 0.100880 66 
6. 0.156777 0.117569 85 0.3033396 0.231508 64 0.369577 0.231508 64 
7. 0.204365 0.110626 60 0.3855038 0.286836 59 0.3898714 0.293402 59 
8. 0.457522 0.176475 53 0.371795 0.346233 32 0.371795 0.326233 32 
9. 0.790476 0.175093 17 0.366667 0.3333333 13 0.396667 0.285702 19 
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P value 0.9951     
P value summary ns     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 0.004906     
R square 0.0003632     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 2.147     
P value 0.3418     
P value summary ns     
Do the variances differ significantly. (P < 0.05) No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.0003976 2 0.0001988 
Residual (within columns) 1.094 27 0.04053 








Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.3354     
P value summary ns     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 1.140     
R square 0.08061     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.9850     
P value 0.6111     
P value summary ns     
Do the variances differ significantly. (P < 0.05) No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.1108 2 0.05541 
Residual (within columns) 1.264 26 0.04862 






CS NP6293/733 UAS-Fzr NP6293  
 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 70 0.000000 0.000000 72 
1. 0.014286 0.034993 75 0.033333 0.081650 70 0.023810 0.062994 72 
2. 0.014286 0.034993 78 0.158658 0.143258 48 0.000000 0.000000 72 
3. 0.028571 0.069985 75 0.215960 0.095320 68 0.019048 0.050395 69 
4. 0.033333 0.053452 90 0.216156 0.148009 70 0.064426 0.126423 70 
5. 0.140000 0.149666 60 0.295421 0.209082 80 0.114466 0.136680 74 
6. 0.156777 0.117569 85 0.331746 0.253082 75 0.232902 0.059495 85 
7. 0.204365 0.110626 60 0.348016 0.085375 74 0.219687 0.155577 72 
8. 0.457522 0.176475 53 0.526389 0.088527 70 0.548571 0.289369 29 
9. 0.790476 0.175093 17 0.720833 0.065793 29       
age in weeks CS  Repo/Highwire UAS Highwire/cyo 
 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 90 0.000000 0.000000 55 
1. 0.014286 0.034993 75 0.071667 0.098773 90 0.000000 0.000000 55 
2. 0.014286 0.034993 78 0.103333 0.203943 80 0.000000 0.000000 56 
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Parameter       
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.5592     
P value summary ns     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 0.5945     
R square 0.04373     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 12.68     
P value 0.0018     
P value summary **     
Do the variances differ significantly. (P < 
0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.03755 2 0.01877 
Residual (within columns) 0.8211 26 0.03158 








CS  Repo/APC2 APC2 
 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 90 0.000000 0.000000 65 
1. 0.014286 0.034993 75 0.025000 0.046291 90 0.000000 0.000000 65 
2. 0.014286 0.034993 78 0.000000 0.000000 80 0.000000 0.000000 65 
3. 0.028571 0.069985 75 0.009615 0.027196 80 0.000000 0.000000 65 
4. 0.033333 0.053452 90 0.012500 0.035355 88 0.000000 0.000000 65 
5. 0.140000 0.149666 60 0.019231 0.054393 68 0.013889 0.034021 67 
6. 0.156777 0.117569 85 0.063492 0.118783 72 0.080037 0.146071 85 
7. 0.204365 0.110626 60 0.050000 0.092582 58 0.311508 0.124850 96 
8. 0.457522 0.176475 53 0.015625 0.044194 49 0.327946 0.100936 35 
9. 0.790476 0.175093 17 0.115079 0.178527 34 0.666667 0.471405 5 
 
 
Parameter       
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.2233     
P value summary ns     
Are means significantly. different? (P < 
0.05) 
No     
Number of groups 3     
F 1.586     
R square 0.1051     
3. 0.028571 0.069985 75 0.083333 0.105409 90 0.044286 0.040880 65 
4. 0.033333 0.053452 90 0.079524 0.118451 70 0.077436 0.006820 64 
5. 0.140000 0.149666 60 0.061728 0.095438 70 0.106667 0.078705 59 
6. 0.156777 0.117569 85 0.076190 0.140617 60 0.325223 0.181162 67 
7. 0.204365 0.110626 60 0.089286 0.104124 60 0.361941 0.263027 60 
8. 0.457522 0.176475 53 0.160409 0.250865 58 0.343590 0.250246 23 
9. 0.790476 0.175093 17 0.247619 0.281033 45       
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Bartlett's test for equal variances       
Bartlett's statistic (corrected) 22.61     
P value < 0.0001     
P value summary ****     
Do the variances differ significantly. (P < 
0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.1239 2 0.06197 
Residual (within columns) 1.055 27 0.03908 







CS  ElavGal4/733UasFzr Elav Gal4 
 MEAN SD N MEAN SD N MEAN SD N 
0. 0.000000 0.000000 75 0.000000 0.000000 70 0.000000 0.000000 37 
1. 0.014286 0.034993 75 0.066667 0.121716 70 0.022222 0.038490 37 
2. 0.014286 0.034993 78 0.085887 0.196670 70 0.000000 0.000000 39 
3. 0.028571 0.069985 75 0.057021 0.084202 60 0.082292 0.084188 51 
4. 0.033333 0.053452 90 0.068980 0.085260 55 0.045635 0.055129 53 
5. 0.140000 0.149666 60 0.078564 0.080654 50 0.088889 0.094281 46 
6. 0.156777 0.117569 85 0.142857 0.142857 40 0.142393 0.162563 50 
7. 0.204365 0.110626 60 0.126164 0.066781 40 0.066667 0.045134 42 
8. 0.457522 0.176475 53 0.125000 0.178406 40 0.269048 0.118283 30 




























Life span monitoring Statistics  
Table 4  
 
a) NP3233/733 UAS-Fzr 
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.6432     
P value summary ns     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 0.4485     
R square 0.03216     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 7.075     
P value 0.0291     
P value summary *     
Do the variances differ significantly. (P < 0.05) No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.02992 2 0.01496 
Residual (within columns) 0.9006 27 0.03336 
Total 0.9305 29   
age in 
weeks 
CS NP3233/733 UASFzr  NP3233 



































CS NP1243/733 NP1243 
 MEAN SD N MEAN SD N MEAN SD N 
0. 1.000000 0.000000 219 1.000000 0.000000 271 1.000000 0.000000 100 
1. 0.966349 0.043893 219 0.904106 0.093887 271 1.000000 0.000000 100 
2. 0.940546 0.058009 219 0.661850 0.243908 271 0.932540 0.133348 100 
3. 0.837855 0.182249 219 0.577768 0.253236 271 0.874459 0.196772 100 
4. 0.720302 0.219872 219 0.413740 0.328874 271 0.774892 0.199242 100 
5. 0.669963 0.246044 219 0.303852 0.315449 271 0.708153 0.261511 100 
6. 0.590579 0.229087 219 0.218927 0.272420 271 0.529942 0.352468 100 
7. 0.460547 0.233090 219 0.182264 0.261425 271 0.454059 0.347014 100 
8. 0.330085 0.180142 219 0.123259 0.201677 271 0.359056 0.309751 100 
9. 0.197590 0.183413 219 0.084366 0.178708 271 0.291141 0.257815 100 
10. 0.122537 0.143709 219 0.046948 0.140845 271 0.153209 0.247659 100 
11. 0.057471 0.099543 219 0.000000 0.000000 271 0.000000 0.000000 0 
 MEAN SD N MEAN SD N MEAN SD N 
0. 1.000000 0.000000 219 1.000000 0.000000 309 1.000000 0.000000 188 
1. 0.966349 0.043893 219 0.673425 0.104304 309 0.935776 0.052220 188 
2. 0.940546 0.058009 219 0.402131 0.156747 309 0.905131 0.073281 188 
3. 0.837855 0.182249 219 0.232912 0.123186 309 0.793696 0.132116 188 
4. 0.720302 0.219872 219 0.113703 0.089557 309 0.710102 0.150282 188 
5. 0.669963 0.246044 219 0.015334 0.028424 309 0.638786 0.192714 188 
6. 0.590579 0.229087 219 0.000000 0.000000 309 0.375597 0.171144 188 
7. 0.460547 0.233090 219 0.000000 0.000000 309 0.148006 0.160253 188 
8. 0.330085 0.180142 219 0.000000 0.000000 309 0.058734 0.132235 188 
9. 0.197590 0.183413 219 0.000000 0.000000 309 0.000000 0.000000 188 
10. 0.122537 0.143709 219 0.000000 0.000000 309 0.000000 0.000000 188 
11. 0.057471 0.099543 219 0.000000 0.000000 309 0.000000 0.000000 188 
12. 0.000000 0.000000 219 0.000000 0.000000 309 0.000000 0.000000 188 
Parameter       
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.0615     
P value summary ns     
Are means significantly. different? (P 
< 0.05) 
Yes     
Number of groups 3     
F 3.016     
R square 0.1435     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.7219     
P value 0.6970     
P value summary ns     
Do the variances differ significantly. (P 
< 0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.8054 2 0.4027 
Residual (within columns) 4.806 36 0.1335 
Total 5.611 38   
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12. 0.000000 0.000000 219             
 
 
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.3109     
P value summary ns     
Are means significantly. different? (P < 
0.05) 
No     
Number of groups 3     
F 1.209     
R square 0.06641     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.05272     
P value 0.9740     
P value summary ns     
Do the variances differ significantly. (P < 
0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.2919 2 0.1460 
Residual (within columns) 4.104 34 0.1207 









Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.5857     
P value summary ns     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 0.5438     
R square 0.03190     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.01730     
P value 0.9914     
age in 
weeks 
CS NP577/733UAS-Fzr NP577 
 MEAN SD N MEAN SD N MEAN SD N 
0. 1.000000 0.000000 219 1.000000 0.000000 315 1.000000 0.000000 99 
1. 0.966349 0.043893 219 0.891986 0.118975 315 0.798981 0.163451 99 
2. 0.940546 0.058009 219 0.765234 0.190346 315 0.798981 0.163451 99 
3. 0.837855 0.182249 219 0.660121 0.162400 315 0.716214 0.151792 99 
4. 0.720302 0.219872 219 0.477339 0.185984 315 0.650424 0.073078 99 
5. 0.669963 0.246044 219 0.329623 0.240574 315 0.527037 0.215910 99 
6. 0.590579 0.229087 219 0.228298 0.198558 315 0.395119 0.264452 99 
7. 0.460547 0.233090 219 0.150140 0.159478 315 0.181621 0.163693 99 
8. 0.330085 0.180142 219 0.049513 0.070357 315 0.058574 0.068328 99 
9. 0.197590 0.183413 219 0.004386 0.013158 315 0.043896 0.050729 99 
10. 0.122537 0.143709 219 0.002924 0.008772 315 0.000000 0.000000 99 
11. 0.057471 0.099543 219 0.000000 0.000000 315       
12. 0.000000 0.000000 219             
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P value summary ns     
Do the variances differ significantly. (P < 0.05) No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.1421 2 0.07105 
Residual (within columns) 4.312 33 0.1307 
Total 4.454 35   
    
 
 
d) NP2222/733 UAS-Fzr 
 
 
Parameter       
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.7958     
P value summary ns     
Are means significantly. different? (P 
< 0.05) 
No     
Number of groups 3     
F 0.2301     
R square 0.01463     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.5484     
P value 0.7602     
P value summary ns     
Do the variances differ significantly. 
(P < 0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.05745 2 0.02873 
Residual (within columns) 3.869 31 0.1248 








CS NP2276/733UAS Fzr NP2276 
 MEAN SD N MEAN SD N MEAN SD N 
0. 1.000000 0.000000 219 1.000000 0.000000 352 1.000000 0.000000 73 
1. 0.966349 0.043893 219 0.932814 0.074715 352 0.958333 0.083333 73 
2. 0.940546 0.058009 219 0.765428 0.197087 352 0.917749 0.068516 73 
3. 0.837855 0.182249 219 0.647382 0.229669 352 0.884416 0.042751 73 
4. 0.720302 0.219872 219 0.543667 0.257492 352 0.762771 0.083243 73 
5. 0.669963 0.246044 219 0.459500 0.287912 352 0.637662 0.076591 73 
6. 0.590579 0.229087 219 0.368587 0.278842 352 0.435281 0.203896 73 
age in 
weeks 
CS NP2222/733UAS Fzr NP2222 
 MEAN SD N MEAN SD N MEAN SD N 
0. 1.000000 0.000000 219 1.000000 0.000000 152 1.000000 0.000000 63 
1. 0.966349 0.043893 219 0.785907 0.215808 152 1.000000 0.000000 63 
2. 0.940546 0.058009 219 0.718887 0.168229 152 0.977273 0.045455 63 
3. 0.837855 0.182249 219 0.614277 0.225389 152 0.803693 0.060597 63 
4. 0.720302 0.219872 219 0.495842 0.165773 152 0.670739 0.113638 63 
5. 0.669963 0.246044 219 0.426927 0.160369 152 0.497159 0.106752 63 
6. 0.590579 0.229087 219 0.370549 0.179161 152 0.305682 0.085371 63 
7. 0.460547 0.233090 219 0.329148 0.215664 152 0.282955 0.106544 63 
8. 0.330085 0.180142 219 0.214242 0.132645 152 0.031250 0.062500 63 
9. 0.197590 0.183413 219 0.072242 0.080204 152 0.000000 0.000000 63 
10. 0.122537 0.143709 219 0.000000 0.000000 152       
11. 0.057471 0.099543 219             
12. 0.000000 0.000000 219             
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7. 0.460547 0.233090 219 0.302591 0.266917 352 0.323377 0.230778 73 
8. 0.330085 0.180142 219 0.247733 0.230130 352 0.139610 0.161295 73 
9. 0.197590 0.183413 219 0.122269 0.178829 352 0.035714 0.071429 73 
10. 0.122537 0.143709 219 0.0852269 0.123709 352 0.015714 0.051429 73 
11. 0.057471 0.099543 219 0.000000 0.000000 352 0.000000 0.000000 73 
12. 0.000000 0.000000 219             
 
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.8734     
P value summary ns     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 0.1359     
R square 0.007932     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.3681     
P value 0.8319     
P value summary ns     
Do the variances differ significantly. (P < 
0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.03589 2 0.01795 
Residual (within columns) 4.489 34 0.1320 









CS NP6520/733 NP6520 
 MEAN SD N MEAN SD N MEAN SD N 
0. 1.000000 0.000000 219 1.000000 0.000000 631 1.000000 0.000000 134 
1. 0.966349 0.043893 219 0.908026 0.107323 631 0.960606 0.062103 134 
2. 0.940546 0.058009 219 0.820921 0.122157 631 0.915170 0.081622 134 
3. 0.837855 0.182249 219 0.721422 0.157074 631 0.735804 0.237597 134 
4. 0.720302 0.219872 219 0.627724 0.206934 631 0.614268 0.209199 134 
5. 0.669963 0.246044 219 0.547562 0.173521 631 0.574585 0.196863 134 
6. 0.590579 0.229087 219 0.404928 0.154401 631 0.430610 0.140098 134 
7. 0.460547 0.233090 219 0.272736 0.144482 631 0.207810 0.130874 134 
8. 0.330085 0.180142 219 0.165498 0.140183 631 0.030754 0.057392 134 
9. 0.197590 0.183413 219 0.089569 0.093761 631 0.007937 0.019440 134 
10. 0.122537 0.143709 219 0.027919 0.039494 631 0.000000 0.000000 134 
11. 0.057471 0.099543 219 0.000000 0.000000 631 0.000000 0.000000 134 
12. 0.000000 0.000000 219             
 
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.8623     
P value summary ns     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 0.1487     
R square 0.008674     
        
Bartlett's test for equal variances       
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Bartlett's statistic (corrected) 0.1643     
P value 0.9212     
P value summary ns     
Do the variances differ significantly. (P < 0.05) No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.04099 2 0.02050 
Residual (within columns) 4.685 34 0.1378 








CS NP6293/733 NP6293 
 MEAN SD N MEAN SD N MEAN SD N 
0. 1.000000 0.000000 219 1.000000 0.000000 331 1.000000 0.000000 199 
1. 0.966349 0.043893 219 0.909583 0.067313 331 0.972815 0.052253 199 
2. 0.940546 0.058009 219 0.876191 0.065062 331 0.945359 0.063191 199 
3. 0.837855 0.182249 219 0.814344 0.109446 331 0.892726 0.092078 199 
4. 0.720302 0.219872 219 0.718739 0.139640 331 0.797186 0.103224 199 
5. 0.669963 0.246044 219 0.667080 0.158847 331 0.682053 0.123472 199 
6. 0.590579 0.229087 219 0.537007 0.161826 331 0.522234 0.108823 199 
7. 0.460547 0.233090 219 0.437856 0.186932 331 0.340550 0.134201 199 
8. 0.330085 0.180142 219 0.329346 0.178571 331 0.139415 0.079164 199 
9. 0.197590 0.183413 219 0.187000 0.219478 331 0.047876 0.083881 199 
10. 0.122537 0.143709 219 0.068627 0.137255 331 0.000000 0.000000 199 
11. 0.057471 0.099543 219 0.000000 0.000000 331       
12. 0.000000 0.000000 219             
 
 
Parameter       
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.9520     
P value summary ns     
Are means significantly. different? (P < 0.05) No     
Number of groups 3     
F 0.04930     
R square 0.002979     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.1606     
P value 0.9228     
P value summary ns     
Do the variances differ significantly. (P < 
0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.01294 2 0.006469 
Residual (within columns) 4.331 33 0.1312 








CS RepoGal4/APC2 APC2 
 MEAN SD N MEAN SD N MEAN SD N 
0. 1.000000 0.000000 219 1.000000 0.000000 117 1.000000 0.000000 60 
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1. 0.966349 0.043893 219 0.943452 0.092041 117 0.981718 0.008176 60 
2. 0.940546 0.058009 219 0.884807 0.133002 117 0.947279 0.051043 60 
3. 0.837855 0.182249 219 0.816571 0.136618 117 0.873318 0.087247 60 
4. 0.720302 0.219872 219 0.773077 0.208374 117 0.783456 0.070554 60 
5. 0.669963 0.246044 219 0.652976 0.232582 117 0.658296 0.096415 60 
6. 0.590579 0.229087 219 0.520991 0.162430 117 0.498158 0.180366 60 
7. 0.460547 0.233090 219 0.276737 0.206719 117 0.390117 0.231786 60 
8. 0.330085 0.180142 219 0.181335 0.172782 117 0.379655 0.181842 60 
9. 0.197590 0.183413 219 0.103064 0.169484 117 0.427160 0.041488 60 
10. 0.122537 0.143709 219 0.142857 0.202031 117 0.400000 0.000000 60 
11. 0.057471 0.099543 219  0 0    117 0 0  60  
12 0 0 219       
 
 
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.7227     
P value summary ns     
Are means significantly. different? (P < 
0.05) 
No     
Number of groups 3     
F 0.3282     
R square 0.02074     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.9411     
P value 0.6247     
P value summary ns     
Do the variances differ significantly. (P < 
0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.06540 2 0.03270 
Residual (within columns) 3.088 31 0.09963 








CS  ElavGal4/733 UAS-Fzr ELavGAL4 
 MEAN SD N MEAN SD N MEAN SD N 
0. 1.000000 0.000000 219 1.000000 0.000000 149 1.000000 0.000000 60 
1. 0.966349 0.043893 219 0.870607 0.122914 149 0.960784 0.055459 60 
2. 0.940546 0.058009 219 0.786534 0.227277 149 0.960784 0.055459 60 
3. 0.837855 0.182249 219 0.695508 0.230917 149 0.947964 0.048979 60 
4. 0.720302 0.219872 219 0.652031 0.249557 149 0.947964 0.048979 60 
5. 0.669963 0.246044 219 0.576845 0.238674 149 0.922323 0.054934 60 
6. 0.590579 0.229087 219 0.489354 0.229350 149 0.763876 0.152309 60 
7. 0.460547 0.233090 219 0.365961 0.216079 149 0.500830 0.055618 60 
8. 0.330085 0.180142 219 0.226130 0.125451 149 0.363235 0.186765 60 
9. 0.197590 0.183413 219 0.110443 0.100057 149 0.362282 0.159081 60 
10. 0.122537 0.143709 219 0.045238 0.073633 149 0.259746 0.177314 60 
11. 0.057471 0.099543 219 0.008929 0.016581 149 0.157210 0.195547 60 
12 0 0 219 0 0 149 0 0 60 
 
 
Parameter       
Table Analyzed Data 1     
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One-way analysis of variance       
P value 0.3718     
P value summary ns     
Are means significantly. different? (P < 
0.05) 
No     
Number of groups 3     
F 1.020     
R square 0.05821     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.02035     
P value 0.9899     
P value summary ns     
Do the variances differ significantly. (P < 
0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.2246 2 0.1123 
Residual (within columns) 3.635 33 0.1101 








cs RepoGal4/UAS Highwire UAS-Highwire/cyo 
0. 1.000000 0.000000 219 1.000000 0.000000 122 1.000000 0.000000 50 
1. 0.966349 0.043893 219 0.876068 0.136685 122 0.888889 0.222222 50 
2. 0.940546 0.058009 219 0.762563 0.216224 122 0.888889 0.222222 50 
3. 0.837855 0.182249 219 0.676138 0.243935 122 0.863649 0.207002 50 
4. 0.720302 0.219872 219 0.567595 0.227787 122 0.823139 0.218587 50 
5. 0.669963 0.246044 219 0.456915 0.229985 122 0.754801 0.189215 50 
6. 0.590579 0.229087 219 0.404232 0.189000 122 0.612485 0.217613 50 
7. 0.460547 0.233090 219 0.285579 0.211123 122 0.403388 0.074761 50 
8. 0.330085 0.180142 219 0.200645 0.134217 122 0.366300 0.092848 50 
9. 0.197590 0.183413 219 0.047741 0.058471 122 0.311343 0.178414 50 
10. 0.122537 0.143709 219 0.000000 0.000000 122 0.000000 0.000000 50 
11. 0.057471 0.099543 219             
 
 
Table Analyzed Data 1     
        
One-way analysis of variance       
P value 0.5805     
P value summary ns     
Are means significantly. different? (P 
< 0.05) 
No     
Number of groups 3     
F 0.5532     
R square 0.03342     
        
Bartlett's test for equal variances       
Bartlett's statistic (corrected) 0.1932     
P value 0.9079     
P value summary ns     
Do the variances differ significantly. 
(P < 0.05) 
No     
        
ANOVA Table SS df MS 
Treatment (between columns) 0.1262 2 0.06310 
Residual (within columns) 3.650 32 0.1141 
Total 3.776 34   
 
 
 
 
